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Abstract 
Anthelminthic drugs have controlled parasitic infections in veterinary species for 
decades, but today this use is questioned due to concerns about antimicrobial 
resistance. For most microorganisms, a feasible alternative is vaccination but for 
parasites, commercial vaccines are scarce. This is partly due to the complex life 
cycles of most helminths together with their immunomodulatory capacity. In the 
horse, Strongylus vulgaris has recently gained attention due to its re-emergence in 
Sweden. The overall aim of the present thesis was therefore to establish ex vivo 
methods to study responses against S. vulgaris that can guide formulation of a future 
vaccine. In the search for relevant antigens, protocols for generating defined larval 
(L) stages were established. These S. vulgaris preparations, alone or in combination
with an adjuvant, were evaluated for their cytokine-inducing capacity. All larval
preparations induced a Th2 profile in equine PBMC characterised by up-regulation
of IL-4, IL-5, IL-9, IL-13 and TSLP. The L4 stage skewed this response by also up-
regulating IFN-γ. The presence of a novel saponin adjuvant affected the Th2 profile
induced by the L3 stage of S. vulgaris. To study responses to S. vulgaris at the site
of infection, equine intestinal stem cells were differentiated into intestinal organoids.
From these, monolayer cultures were established that displayed both genetic and
functional similarities with the equine intestine, expressing pro-inflammatory
cytokine genes at exposure to TLR-agonists. These organoid monolayers were
applicable for generation of ex vivo co-cultures with equine PBMC and S. vulgaris
larvae. Overall, this thesis provides new insights into the biology of S. vulgaris
infection and ex vivo methods that will aid in the development of a future vaccine.
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Sammanfattning 
Anthelmintika har under en lång tid varit ett effektivt sätt att bekämpa 
parasitinfektioner hos djur. På grund av risken för utveckling av läkemedelsresistens 
har användningen av anthelmintika numera ifrågasatts. Det rimliga alternativet för 
att kontrollera de flesta mikroorganismer är genom vaccin, men mot parasiter finns 
det väldigt få kommersiella vaccin. Detta beror dels på parasiters komplexa 
livscykler och dels på deras förmåga att manipulera immunförsvaret. Strongylus 
vulgaris har på senare tid blivit uppmärksammad med anledning av en ökad 
förekomst i Sverige. Målet med denna avhandling var därför etablera metoder för att 
studera immunreaktioner mot S. vulgaris som kan vägleda framtida formuleringar 
av ett vaccin. För att identifiera relevanta antigen etablerades metoder för odling av 
olika S. vulgaris larvstadier. Dessa larvpreparationer, ensamma eller i kombination 
med ett adjuvans, utvärderades för deras cytokininducerande förmåga. Alla 
larvstadier inducerade en Th2 profil i ekvina mononukleära blodceller (PBMC) 
genom upp-reglering av gener för IL-4, IL-5, IL-9, IL-13 and TSLP. L4 stadiet 
skiljde sig däremot från de tidigare larvstadierna genom att även uppreglera IFN-γ. 
Närvaron av ett saponinbaserat adjuvans påverkade Th2 profilen inducerat av S. 
vulgaris L3. För att studera rektioner mot S. vulgaris i tarmen etablerades 
cellkulturer från stamceller isolerade från hästens tarm, s.k. organoider. Från dessa 
utvecklades s.k. monolayers bestående av ett enskiktat lager av celler vilka visade 
både genetiska och funktionella likheter med hästens tarm, samt uttryckte gener for 
pro-inflammatoriska cytokiner vid exponering för TLR-agonister. Dessa monolayers 
kunde samodlas med ekvina PBMC och S. vulgaris larver. Sammanfattningsvis har 
denna avhandling genererat nya insikter om immunsvaret vid S. vulgaris infektion 
samt ex vivo metoder som kan användas i utvecklingen av ett framtida vaccin.   
Nyckelord: Strongylus vulgaris, enteroider, häst, PBMC, parasit, ex vivo  
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Helminth parasite infections are widespread among all animal species 
affecting animal health and performance resulting in negative consequences 
for the agricultural sector (Foster & Elsheikha, 2012). The discovery of 
broad-spectrum anthelminthic compounds in the 1960s revolutionized both 
animal and human health. For the first time in history, parasite infections 
could be controlled leading to a reduced morbidity and mortality from 
parasitic disease. In the equine sector, anthelminthic treatments several times 
per year were originally aimed to control the large strongyle parasite 
Strongylus vulgaris. This treatment regime was extremely effective in 
reducing worm burdens, making S. vulgaris an uncommon equine parasite 
(Kaplan & Nielsen, 2010). Unfortunately, the frequent usage of 
anthelminthic drugs backfired as drug resistance emerged in other equine 
parasite species. Today, resistance against anthelminthic drugs is a 
recognized problem in the equine roundworm Parascaris univalens and 
small strongyles Cyathostominae spp. (reviewed by Raza et al, 2019). 
 
 To slow down the development of anthelmintic resistance, the European 
Union (2001/82/EG) issued treatment restrictions in 2007. In the Nordic 
countries, this was applied in practice by so-called “targeted selective 
treatment”, by determining strongyle fecal egg counts (EPG) for all horses 
and only treat those exceeding a predetermined threshold. The aim were to 
achieve a reduction of overall egg shedding, while leaving a proportion of 
the herd untreated, which lowers anthelminthic treatment intensity and 
reduces selection pressure for development of anthelmintic resistance. 
However, reports from Sweden and Denmark show that the prevalence of S. 
vulgaris has increased the last years, coinciding with the new treatment 
1. Introduction 
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regime (Nielsen et al, 2012; Tydén et al., 2019) despite advices about 
improved pasture management routines (Hedberg-Alm et al, 2020).  
 
With no novel anthelminthic drugs in sight (Nixon et al, 2020), alternative 
methods to control S. vulgaris, such as vaccination, are therefore warranted.  
Indeed, before the “era of anthelminthics”, efforts were made to develop 
vaccines against a variety of helminths for several animal species, including 
the horse (Bain, 1999). The early attempts to produce vaccines against S. 
vulgaris used irradiated larval preparations as antigen (Klei et al, 1982; 
Monahan et al, 1994; Swiderski et al, 1999). These vaccines gave partial 
protection but were not further progressed when anthelminthic oral pastas 
became commercially available.    
 
It is generally accepted that making vaccines against helminths is 
troublesome. Typically, helminths establish long-term chronic infections 
that cannot be resolved by the host’s immune defense. This evasion is at least 
partly thought to rely on the helminth’s ability to modulate the host’s 
immune response. Three major obstacles for successful development of 
helminth vaccines can be summarized: (1) identification of relevant antigens 
from the parasite; (2) identification of the host’s protective mechanisms, and 
(3) development of the appropriate stimuli needed to mobilize these 
pathways while at the same time overcoming the intrinsic immune regulatory 
capabilities of the parasite. Thus, knowledge about the biology of infection 
for the parasite of choice needs to be deepened to select relevant antigen(s) 
and adjuvant for vaccine formulation. Furthermore, a suitable ex vivo model 
is needed for initial screening of the proposed components.  
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2.1 Helminths and the immune defense 
Parasitic helminths comprise the three taxonomic groups nematodes 
(roundworms), trematodes (flukes) and cestodes (tapeworms). They all differ 
in host and tissue specificity with different invasion routes and life-cycle 
pathways, making them a very heterogeneous group of organisms. However, 
the gastro-intestinal (GI) nematodes are similar in that they progress from 
eggs through multiple developmental stages, commonly referred to as “larval 
(L) stages” until becoming adult worms. The various developmental stages 
are separated by molting events when the cuticle surrounding the larval body 
is released. These shifts between larval stages are typically fast and often 
accompanied by migrations through different organs and tissues 
(Wiedemann & Voeringer 2020). In addition, molecules produced and 
released by helminths referred to as excretory-secretory (ES) products are 
immunomodulatory, meaning that they can interfere with the host’s immune 
response (Maizels et al, 2018). 
 
Most knowledge of nematode immunity comes from rodent laboratory 
models and the effector mechanisms necessary for elimination of GI 
nematodes of large animal species, such as the horse, have only been partly 
delineated (Foster & Elsheikha, 2012; Grencis 2015). Because of the 
migrating life cycle of S. vulgaris, the host’s immune system is likely to be 
exposed to various antigen setups, representing different larval stages in 
different immune compartments including blood and intestinal mucosa. 
Below, I will give a brief overview of immune mechanisms generally 
involved in recognition, processing and elimination of GI helminths.     
2. Background  
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2.1.1 Innate immune recognition  
When a pathogen first infects a host, two types of alarm signals can trigger 
the immune defense that either sense molecular structures originating from 
the pathogen (pathogen associated molecular patterns; PAMPs) or from 
damaged tissue (danger associated molecular patterns; DAMPs). The 
PAMPs and DAMPs are recognized by pattern recognition receptors (PRRs) 
expressed by innate immune cells such as dendritic cells (DCs), 
monocytes/macrophages, mast cells, granulocytes, natural killer (NK) cells 
and innate lymphoid cells (ILCs), but also by other cell types such as 
epithelial cells (reviewed in Kumar et al, 2011; Constant et al, 2021). There 
are several types of PRRs with different cellular localizations recognizing a 
vast array of conserved motifs expressed by microorganisms (Li and Wu, 
2021). Although, there is no PAMP uniform for helminths, multiple types of 
PRRs can recognize helminth molecules. Of these, Toll-like receptors 
(TLRs), C-type lectin receptors (CTRs) and NOD-like receptors (NLRs) 
have most frequently been associated with helminth recognition (Perrigoue 
et al, 2008; Motran et al, 2018). The invasive nature of most GI nematodes 
also results in release of DAMPs from injured tissue. Recognition of PAMPs 
or DAMPs by PRRs rapidly trigger induction of inflammatory mediators 
such as cytokines and chemokines, which initiate and coordinate the ensuing 
immune response.  
 
Cytokines are small secretory proteins that regulate most elements of the 
immune system and play a fundamental role in initiation of immune 
responses. Some cytokines have pleiotropic effects while others only induce 
a limited set of actions. Chemokines are cytokines able to act chemotactic 
for immune cells. Thus, chemokines are especially important to attract 
immune cells to the site of infection but also essential for cell trafficking at 
homeostasis. The kind of cytokines and chemokines that are elicited in 
response to a PAMP or DAMP influences the ensuing immune response 
(Borish & Steinke, 2003). Traditionally, helminth infections are associated 
with secretion of the cytokines interleukin-(IL)-4, IL-5, IL-9, IL-13 along 
with the alarmins IL-25, IL-33 and thymic stromal lymphopoietin (TSLP) 
that all together support the initiation of a T helper cell type 2 (Th2) response 
(discussed in 2.1.6).  
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2.1.2 Induction of acquired immunity  
To initiate an antigen-specific immune response, the pathogen needs to be 
detected, engulfed and presented by professional antigen presenting cells 
(APCs). The most efficient APCs are the DCs, although other cell types such 
as macrophages and B-cells also can act as APCs. Interesting out of a parasite 
perspective are the eosinophilic granulocytes that also seem to be able to 
present antigens, although much less effective compared to DCs (Makepeace 
et al, 2012). Once a DC is activated, it migrates to the draining lymph node 
where it presents antigen peptides on MHC class II molecules to naïve CD4+ 
T helper (Th) cells. Activation and priming of naïve T cells requires three 
signals: (1) the antigen presented on MHCII is recognized by the T cell 
receptor (TCR); (2) co-stimulatory molecules on the DC bind to 
activation/deactivation receptors on the T cell; (3) priming cytokines guide 
differentiation to particular Th subsets specialized to induce different 
effector functions. However, T cell receptor engagement in the absence of 
signals 2 or 3 induces tolerance, and prolonged cytokine stimulation as well 
as cytokine pre-exposure can exhaust and/or impair the T cell response 
(Sckisel et al, 2015). Thus, persistent infections are likely to modulate the 
host’s immune response, hindering development of an antigen-specific 
immune response, as seen for most helminth infections (Hewitson & 
Maizels, 2014). If, however, successfully primed, Th cells will migrate 
towards the B cell zone to aid B cell differentiation into plasma cells and 
antibody class switching.  
 
2.1.3 Antibody-mediated immunity  
Helminth infections in mice are typically associated with elevated serum 
levels of the Th2 associated antibody subclasses IgE and IgG1 (Sorobetea et 
al, 2018). However, studies in sheep reveal that other IgG subclasses as well 
as IgA are induced at mucosal surfaces by different larval stages of GI 
helminths (Aboshady et al, 2020). In horses, early characterizations of equine 
IgG identified the five subclasses IgGa, IgGb, IgGc, IgG(T) and IgG(B). In 
current literature, seven equine IgG subclasses, designated IgG1-IgG7 are 
recognized. The former IgGa now corresponds to IgG1 and IgG2, IgG(T) 
corresponds to IgG3 and IgG5, IgGb corresponds to IgG4, and IgGc 
corresponds to IgG6 and IgG7 (Wagner, 2006). In addition, equine IgM, IgA 
and IgE have been described, which along with some of the seven IgG 
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subclasses can be quantified using a multiplex assay (Keggan et al, 2013). 
Although studies on antibody responses to equine parasites are limited, both 
S. vulgaris and cyathostomins, as well as the protozoan parasite Theileria 
equi, have been associated with increased levels of IgG(T) in serum 
(Dowdall et al, 2002; Mealey et al, 2012; Andersen et al, 2013a) indicating 
that this subclass (IgG3/IgG5 in present nomenclature) is induced by 
extracellular pathogens. A role for IgE at GI nematode infection in horses 
has been suggested (Pittaway et al, 2014) although not yet extensively 
evaluated in this context. Equine IgE is however known to mediate type 1 
hypersensitivity reactions to Culicoides midge bites (Schaffartzik et al, 
2012).  
 
The majority of plasma cells residing in the intestinal mucosa express IgA. 
Class switching to IgA is supported by multiple factors, but the most 
important is transforming growth factor (TGF)-β. This cytokine enables 
development of antigen-specific IgA, propagation of long-lived plasma cells 
and memory B cells (Lycke & Bemark, 2017). IgA antibodies that are 
secreted into the intestinal lumen occur in dimers paired by the J-chain 
protein. J-chain ligation to the polymeric Ig receptor (plgR) expressed on the 
basolateral surface of the epithelium mediates uptake and transport into the 
intestinal lumen. In the lumen, the secreted IgA (sIgA) can bind to antigens 
on both commensals and pathogens, to neutralize or inhibit their functions as 
well as facilitate antigen transport and presentation by mucosal DCs (Bunker 
& Bendelac, 2018). As in other mammal species, sIgA is the dominating 
isotype in nasopharyngeal secretions and saliva of horses (Palm et al, 2016; 
Schnabel et al, 2017). Molecular characterization of the equine IgA system, 
including J-chain and pIgR, show both genetic and functional similarities 
with human IgA (Lewis et al, 2010). In addition, there is a high level of 
homology between human and equine FcαRI (Morton et al, 2005) suggesting 
that equine IgA can mediate cellular effector responses similar to those 
described in man. Yet, equine IgA has mostly been studied in the context of 
respiratory infections (e.g. Crouch et al, 2005; Bordin et al, 2014; Bannai et 
al, 2021) and there is a limited knowledge about IgA at GI infection in the 
horse. However, a recent pilot study found a positive correlation between 
strongyle EPG and sIgA in feces (Żak et al, 2021), indicating a role of IgA 




2.1.4 Cell mediated immunity  
The T helper cells can be further divided into subsets based on their cytokine 
profile and transcription factors. In mice, Th1 and Th2 cells were first 
discerned based on their ability to produce IL-2 and IFN-γ or induce switch 
to IgG1 and IgE at in vitro stimulations (Mosmann et al, 1986). In 
accordance, human Th1 cells producing IL-2 and IFN-γ could be 
discriminated from Th2 cells producing IL-4 and IL-5 at in vitro stimulation 
with antigens from Mycobacterium tuberculosis and Toxocara canis, 
respectively (Del Prete et al, 1991). From these early studies, Th1 cells 
producing IFN-γ are regarded as protective against infection by virus, 
intracellular bacteria and protozoa, while Th2 cells producing IL-4 are 
supposed to contribute to the protection against helminths.  
Since the first description of Th1 and Th2 cells, other Th subsets have 
been identified such as T regulatory cells (Treg) that can control immune 
reactions by secretion of the immunosuppressive cytokines TGF-β and IL-
10 (Josefowicz et al, 2012). Th17 cells are characterized by a high production 
of IL-17 and shown to be protective against some extracellular bacteria and 
fungi but also associated with autoimmune disease (Harrington et al, 2006). 
In the horse, similar Th subsets have been identified mainly characterized by 
their cytokine profile (Wagner et al, 2010) or their transcriptional profile 
(Fedorka et al, 2021). 
 
  The more recently described Th9 subset develops in the presence of 
TGF-β and IL-4 and its effector functions have been associated with allergy 
and autoimmune disease as well as with helminth immunity (Kaplan, 2013; 
Licona-Limón et al, 2017).  Cytokines from activated Th cells can also 
differentiate CD8+ T cells to cytotoxic T cells (CTLs). However, CTLs are 
mostly associated with intracellular infection and assumed to play a little role 
at GI helminth infection (Sorobetea et al, 2018). 
 
The Th1, Th2 and Th17 cells seem to have their innate lymphoid cell 
(ILC) counterparts referred to as ILC1s, ILC2s or ILC3s (reviewed by Vivier 
et al, 2018; Panda & Colonna, 2019). These cells lack antigen-specific 
receptors but are activated via receptors for alarmins, neurotransmittors and 
components from nutrients and microorganisms. The type 2 innate lymphoid 
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cells (ILC2s) have emerged as a major producer of type 2 cytokines, 
predominantly IL-5 and IL-13, in response to GI helminths (Neill et al, 2010; 
Price et al, 2010). In contrast to Th2 cells, ILC2s do not require antigen 
presentation, but are rapidly activated by cytokines and DAMPs, 
predominantly by the alarmins IL-33, IL-25 and TSLP released from 
parasite-infected tissue. In response to the alarmins, ILC2s produce IL-5 and 
IL-13 that support recruitment of eosinophils, Th2 cell differentiation and 
tissue repair (Lloyd & Snelgrove, 2018). Moreover, ILCs express MHCII 
and can interact with naïve T cells in vitro and promote Th2 polarization in 
vivo (Mirchandani et at, 2014; Oliphant et al, 2014). The maintenance of 
ILC2s is further supported by IL-2 secreted by Th2 cells suggesting a mutual 
cooperation between Th cells and ILC2s during the immune response 
(Mirchandani et at, 2014).  Thus, ILC2s are not only important for initiating 
local responses; they also seem to play a central part in bridging the innate 
and adaptive immune response together to support development and 
maintenance of a Th2 response. 
 
Another link between the innate and adaptive immune response seem to 
be formed by the gamma-delta T cells (γ/δ T) that shape the cytokine profile 
according to the type of infectious agent they encounter (Ferrik et al, 1995). 
The γ/δ T cells are rarely found in lymphoid organs. Instead, they reside in 
barrier surfaces of many peripheral tissues, such as the intestinal mucosa, 
where they play a key role in immune surveillance (Suzuki et al, 2020). A 
role for γ/δ T cells at helminth infection was demonstrated by Inagaki-Ohara 
et al (2011) showing that the γ/δ T cells are an important source of IL-13, 
necessary for expulsion of the murine GI helminth Nippostrongylus 
brasiliensis. 
 
Both ILCs and γ/δ T cells are mainly residing in the mucosal tissue. In 
fact, the intestine harbor the largest population of immune cells anywhere in 
the body (as reviewed in humans by Mörbe et al, 2021). Resident immune 
cells are scattered in the lamina propria and epithelium or reside in gut 
associated lymphoid tissues (GALT). The GALT includes infiltrates of the 
lamina propria, isolated lymphoid follicles, Peyer’s patches and mesenteric 
lymph nodes. The Peyer’s patches are organized clusters of lymphoid 
follicles that are important sites for initiation of antigen-specific immune 
responses. The epithelial monolayer lining the lymphoid follicles differ from 
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the normal epithelium that it consists of enterocytes interspersed with 
specialized epithelial cells called microfold (M) cells. A limited presence of 
mucus secreting cells, like goblet cells, makes the follicle-associated 
epithelium directly exposed to luminal contents. In the absence of damage to 
the epithelium, the M cells serve as a gateway for antigen transport from the 
intestinal lumen to the lymphoid follicle. Luminal antigens can also be 
captured via other routes, e.g. through internalization in goblet cells (McDole 
et al, 2012) or by transepithelial macrophages or DCs (Rescigno et al, 2001).  
 
 In horses, the mucosal associated lymphoid tissue (MALT) has been less 
studied in the gut compared to the respiratory tract. Unique for horses, as 
well as for some ruminants and pigs, is the long oval shape of the Peyer’s 
patches in the small intestine. In the horse, the Peyer’s patches develop 
during gestation, reaching a size of 20-35 cm in newborn foals. The size of 
the Peyer’s patches increases with age and remain in constant numbers for 
the first couple of years before gradually disappearing in the elderly horse 
(Liebler-Tenorio & Pabst, 2006).    
 
2.1.5 Equine PBMC 
Peripheral blood mononuclear cells (PBMC) are commonly used to 
assess immune capacity in human and veterinary medicine. Isolation of 
PBMCs by density gradient centrifugation generates a mix of immune cells 
including a low proportion of monocytes, DCs, ILCs and NK cells, the 
majority being T and B-lymphocytes and thus reflecting aspects of a 
systemic immune response. In parasitological research, ovine and caprine 
PBMCs have been used to study immune reactions to worm antigens (e.g. 
Wang et al, 2019; Jacobs et al, 2020; Naqvi et al, 2020) and equine PBMCs 
isolated from S. vulgaris infected horses were used to study the re-call 
response to S. vulgaris antigens (Dennis et al, 1993).  
 
Several reagents for phenotyping of equine PBMC (eqPBMC) are 
available but overall the reagent toolbox is very limited compared to both 
mice, humans and many other animal species (Kydd et al, 1994; Lunn et al, 
1998; Flaminio et al 2007; Ibrahim et al, 2007). Notably, several important 
T-cell markers e.g. discriminating α/βTCR and γ/δTCR, are missing. 
However, transcriptional analysis of both α/βTCR and γ/δTCR have 
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previously identified these cells in eqPBMCs (Tschetter et al, 1997). For 
equine T cells, only antibodies to equine CD3, CD4, CD8a and CD8b have 
been developed (Lunn et al, 1998). All three DC subsets, DC1, DC2 and 
plasmacytoid DCs (pDCs) have previously been confirmed in eqPBMC 
where pDCs were shown to produce large amounts of IFN-α upon TLR9 
activation (Ziegler et al, 2016).  
 
As an alternative, cytokine profiles elicited at antigen exposure can be 
used to characterize the T cell response. Such functional studies of eqPBMC 
are at large comparable to other mammals, as demonstrated by the gene- and 
microRNA profiles induced by lipopolysaccharide from E. coli in eqPBMC 
(Pacholewska et al, 2017; Parkinsson et al, 2017). However, there seem to 
be some species-specific differences in the reactivity to TLR stimulation 
making it problematic to translate results obtained from other species directly 
to the horse (Figueiredo et al, 2009; Wattrang et al, 2012; Vendrig et al, 2013; 
Pacholewska et al, 2017).  
 
Recently, the cellular landscape of eqPBMC was mapped using a single 
cell RNA sequencing approach (Patel et al, 2021). This transcriptional 
profiling of CD3+ lymphocytes confirmed different clusters of CD4+ and/or 
CD8+ expressing cells as well as indicated the presence of equine γ/δ T cells 
and NK cells (Patel et al, 2021). Unexpectedly, the majority of B cells in the 
eqPBMCs were T-bet+ memory B cells. This is a B cell subpopulation that 
in humans has been associated with both protective and pathogenic immune 
responses (Knox et al, 2019), but the role of equine T-bet+ B cells remain to 
be elucidated. Moreover, the study demonstrated that several immune cell 
subpopulations, such as different subtypes of monocytes and DCs, were 
analogous to those described in human and mouse (Patel et al, 2021).  
 
 
2.1.6 Effector mechanisms against GI helminths 
A Th2 response results in physiological changes in the intestine 
characterized by increased gut contractility, goblet- and tuft cell hyperplasia, 
faster epithelial cell turnover and increased mucus production that together 
facilitate helminth expulsion from the intestinal lumen. This response is 
commonly referred to as the “weep and sweep response” (Sorobetea et al, 
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2018). Essential for initiation of this response are the until recently neglected 
tuft cells (Schneider et al, 2019) and the newly described ILC2s (Vivier et 
al, 2018). Tuft cells are epithelial cells that can sense unknown helminth 
PAMPs and respond with production of TSLP and IL-25. These cytokines, 
together with the alarmin IL-33 that are released by damaged epithelial cells, 
activate ILC2s resident in the underlying mucosa. In return, ILC2s produce 
large amounts of type 2 cytokines, such as IL-13, that further activates the 
tuft cells. Interaction of IL-13 with the IL-4α receptor affects stem cell 
differentiation and promotes tuft cell hyperplasia, thus creating a positive 
feedback loop between tuft cell-produced IL-25 and ILC2-produced IL-13 
(von Moltke et al, 2015; Gerbe et al, 2016). Together with IL-4, mainly 
released by Th2 cells, IL-13 mediates goblet cell hyperplasia and increased 
mucus production important for helminth expulsion (Gerbe et al, 2016). 
 
One of the early-recruited cell population that is a hallmark for helminth 
infection is the eosinophilic granulocyte. The presence of IL-5 can activate 
eosinophils to release granules containing a cocktail of toxic compounds. 
This degranulation can however be mediated through multiple pathways 
such as PRR ligation, cytokine activation, or Fc receptor engagement 
(Makepeace et al, 2012). Similar mechanisms are effectuated by basophils 
and mast cells that release massive amounts of chemical mediators upon 
ligation of IgE to the high-affinity FcεRI. The role of mucosal mast cells and 
IgE in host protection against GI helminths has however been debated as not 
all experimental models demonstrate a protective role for mast cells 
(reviewed by Grencis, 2015). Regardless, mast cells, basophils and 
eosinophils are early sources of IL-4 at helminth infection making them 
important for initiating and maintaining Th2 responses (Anthony et al, 2007; 
Makepeace et al, 2012).  
 
Helminth infection are also known to cause differentiation of 
“alternatively activated macrophages” (AAMs). These AAMs contribute to 
helminth resistance by controlling pro-inflammatory- and Th1 reactions, 
promoting Th2 responses and supporting wound healing (Kreider et al, 
2007). In addition, AAMs can together with neutrophils, DCs and Th2 cells 
contribute to the formation of granulomas, shown to be essential for 
protection against the murine GI nematode H. polygyrus (Anthony et al, 
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2006). However, granuloma formation enables the parasite to “hide” and can 
thereby contribute to persistence of the infection.  
 
The production of excretory/secretory (ES) products also enables 
helminths to interfere with the host’s immune response creating a skewed 
immune phenotype unable to clear the infection. ES products can be both by-
products from the helminth’s metabolism or actively secreted products that 
facilitate the helminth’s establishment and survival in the infected tissue. ES 
products comes in various forms and can consist of various types of 
molecules, commonly proteins, lipids or glycoproteins. Most studied are the 
protein modulators, which are known to act on every phase of the immune 
response, from antigen recognition to effector mechanisms. Many ES 
proteins enhance Treg responses, skew the expression of Th polarizing 
cytokines or reduce the Th proliferation (reviewed by Maizels et al 2018). 
The recent discovery of helminth excreted extracellular vesicles (EVs) has 
further expanded the repertoire of immune modulatory ES products. The 
excretion of EVs provide an opportunity for helminths to deliver fragile 
material into host cells, often micro RNA, (miRNA) that e.g. can interfere 
with expression of immune related genes (Tritten & Geary, 2018). Several 
studies have demonstrated that induction of an antibody response that block 
ES proteins results in a higher expulsion rate and/or reduced egg burden 
(Maizels et al, 2018). Accordingly, EVs have been used as antigen in 
experimental vaccines against the murine nematodes Heligosomoides 
polygyrus and Trichuris muris, and the trematodes Opisthorchis viverrini 
and Echinostoma caproni generating EV-specific antibodies and reduced 
egg burden after challenge (Trelis et al, 2016; Coakley et al, 2017; Shears et 
al, 2018; Chaiyadet et al, 2019). 
 
2.2 Strongylus vulgaris 
Strongylus vulgaris is considered to be the most pathogenic parasite of 
horses. This parasite belongs to the superfamily Strongyloidea containing 
equine nematodes of the intestinal tract, including Cyathostominae spp. 
(small strongyles), Strongylus edentatus and Strongylus equinus (Nielsen & 
Reinemeyer, 2018). The members of this superfamily are alike in several 
aspects, e.g. they share a similar morphology, they have a direct life cycle, 
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the infective stage is the L3 stage and the only method to differentiate 
between the species is through fecal culture and subsequent morphological 
assessment of the larvae or by real-time PCR (Nielsen et al, 2008; Kaspar et 
al, 2017). Moreover, the cyathostomins are highly abundant in the horse 
population resulting in that S. vulgaris most often occurs in co-infection with 
cyathostomins.  
 
2.2.1 Life cycle 
The life cycle of S. vulgaris consists of a free-living and a parasitic phase 
(Figure 1). Eggs are shed on the pasture through faeces of infected horses. 
First stage larvae (L1) hatches from the eggs, develop to L2 and then to 
infective L3 stage larvae. At the free-living stage, the L3 are encapsulated in 
their L2 cuticle that serves as a protection against environmental conditions. 
When a horse ingests L3, the L2 cuticle is cast off in the alimentary tract, in 
a process called exsheatment. The exsheated L3s (exL3) penetrate the 
mucosa and submucosa of the distal small intestine, cecum and/or colon. 
After two to three days in the submucosa, the exL3 moults into a fourth stage 
(L4). The L4 stage of S. vulgaris penetrates the arterioles in the submucosa, 
reaches the mesenteric arteries and continue their migration through the 
arterial system, against the blood flow, until reaching the cranial mesenteric 
artery about 14 days post infection. There, the L4s continue to grow for three 
to four months before they molt into the fifth stage (L5) that finally migrates 
back to the large intestine. When the pre-adult L5 larvae reaches the large 
intestine, the larvae are encapsulated in small nodules in the intestinal wall. 
Eventually these nodules rupture to release adult larvae into the intestinal 
lumen where the larvae need six to eight more weeks to sexually mature and 
produce eggs. Together, these extensive migrations can take between 6-7 
months (McGraw & Slocombe, 1976). This long pre-patent period 
complicates the diagnosis of S. vulgaris infection as most available 
diagnostic tests for S. vulgaris infection are based on cultivation of L3 from 





Figure 1. Life cycle of S. vulgaris.
2.2.2 Pathogenesis
The pathology of S. vulgaris is related to the larval migration and has been 
described in detail by Duncan & Pirie (1975). Notably, already at two days 
post infection haemorrhagic foci can be observed in the intestinal mucosa.  
After a few days more, a local inflammatory response occurs in the 
submucosa. This response is characterised by infiltration of neutrophils, 
lymphocytes, macrophages, and eosinophils and is coincident with L4 
maturation. During the next following weeks, signs of infarction, thrombosis 
and thickening of the mesenteric arteries can be observed. At this early phase 
of infection, tortuous fibrin tracts are found in the intimal space of the 
arteries. The late L4 and L5 stages are associated with lesions and clot 
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formation in the cranial mesenteric and ileo-cecal-colic arteries (Duncan & 
Pirie, 1975). Thus, the larval migration of S. vulgaris can cause severe 
damage to the blood vessels supplying the intestine, potentially resulting in 
life-threatening non-strangulating intestinal infarction (Pihl et al, 2018). 
2.2.3 Immune response 
Early studies show that the immune response against migratory S. vulgaris 
larvae is characterized by recruitment and activation of eosinophils and 
neutrophils (Turk & Klei, 1984; Dennis et al, 1992; Dennis et al, 1993; 
Monahan et al, 1994) as well as production of antibodies (Klei et al, 1983; 
Swiderski et al, 1999). Increased levels of IgM, IgGa, IgGb, IgG(T) and IgA 
have been recorded at S. vulgaris infection (Swiderski et al, 1999). Out of 
these, IgGa, IgG(T) and IgA have been associated with immune protection 
(Swiderski et al, 1999; Edmonds, 2001).  
 
Several early studies especially highlighted eosinophils as very important 
for S. vulgaris resistance. This activation was demonstrated by a higher 
frequency of eosinophils expressing Fc and complement receptors in S. 
vulgaris infected horses compared to that in uninfected horses (Dennis et al, 
1988). Another study showed that eosinophils, but not neutrophils, from S. 
vulgaris infected ponies were able to kill S. vulgaris larvae in an antibody 
dependent manner in vitro (Klei et al, 1992). In addition, cytokines 
chemotactic for eosinophils were found in supernatants from cultures of 
PBMC obtained from S. vulgaris immune ponies, but not in cultures of 
PBMC obtained from naïve ponies, at in vitro re-stimulation (Dennis et al, 
1993). In accordance, gene expression analysis of cytokines in PBMC from 
experimentally infected horses revealed an up-regulation of IL-5 two weeks 
post infection (Swiderski et al, 1999). 
2.2.4 Vaccination trials 
In the 1980s and 90s, experimental immunizations using attenuated S. 
vulgaris L3 were conducted by researchers at the University of Kentucky, 
USA. S. vulgaris L3 were attenuated using Cobalt60 radiation and different 
doses were tested on pony foals by oral inoculations (Klei et al, 1982). 
Overall, immunization with radiation-attenuated S. vulgaris L3 reduced both 
the larval burdens and clinical signs at challenge infections (Klei et al, 1982; 
Monahan et al, 1994; Swiderski et al, 1999). The immunized ponies did not 
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develop thrombosis or arteritis but instead showed signs of periportal fibrosis 
in the intestinal submucosa indicating that the protective immune response 
was directed against the late L3 or L4 stage of larval development. 
Intramuscular injection of crude soluble homogenates from larval (L3 and 
L4) preparations together with a Ribi adjuvant induced higher pre-challenge 
antibody titres compared to the recipients of attenuated larvae, but did not 
generate immune protection. On the contrary, parental immunization with 
somatic extracts seemed to sensitize these ponies resulting in a heightened 
response to challenge (Monahan et al, 1994).  
 
The partial protection from oral immunization with attenuated L3s was 
associated with activation of eosinophils and production of S. vulgaris-
specific antibodies reinforcing that this combined response is important for 
protection (Dennis et al, 1988; Klei et al, 1992; Monahan et al, 1994). The 
levels of antibodies specific for a soluble adult worm antigen (SAWA) from 
S. vulgaris, was estimated in vaccinates and non-vaccinates following 
challenge (Dennis et al, 1992). Both vaccinates and non-vaccinates produced 
similar levels of SAWA-specific IgM, IgGa and IgGb while only the 
vaccinates produced IgG(T) following challenge. In addition, the levels of 
IgA increased in both experimental groups after challenge but reached higher 
levels in the non-vaccinates. Transcriptional analysis of cytokine genes 
indicated an increase in IL-4 and IL-5 and a decrease in IL-2 and IFN-γ 
expression in the vaccinated group following challenge. A similar response 
was recorded for non-vaccinates but appeared to be temporarily delayed 
compared to vaccinated ponies (Swiderski et al, 1999). 
Despite these promising results, the emergence of efficient and easily 
administrated anthelminthic drugs in the 1980-90s made development of 
parasite vaccines less prioritized, resulting in that the S. vulgaris vaccine 
project in Kentucky ceased in the late 90s and changed focus to improve the 
diagnostics of S. vulgaris. 
 
2.2.5 SvSXP 
For the purpose of developing an immunodiagnostic assay indicating 
prepatent S. vulgaris infection, a protein expressed by migrating S. vulgaris 
larvae, designated SvSXP, was identified (Andersen et al, 2013b). By 
screening a larval S. vulgaris cDNA library using hyperimmune serum raised 
33 
against S. vulgaris ES antigens, SvSXP was identified as the only positive 
clone, indicating that SvSXP is an immunodominant protein (Andersen et al, 
2013a; 2013b). Sequence analysis revealed that SvSXP is homologous to the 
SXP/RAL-2 group of proteins that exists in a broad range of nematodes. 
Interestingly, some of the SXP/RAL-2 protein family members have been 
evaluated as vaccine candidates against several nematode species, such as 
Ascaris suum, Brugia malayi and Ancylostoma caninum (Wang et al, 1997; 
Tsuji et al, 2001; Fujiwara et al, 2007; Wei et al, 2017).  
 
A recombinant SvSXP protein is currently used as antigen in an enzyme-
linked immunosorbent assay (ELISA) to measure SvSXP-specific IgG(T) 
antibodies in the bloodstream of horses (Andersen et al, 2013b; Nielsen et al, 
2014; Nielsen et al, 2015; Hedberg-Alm et al, 2020). In a cohort of naturally 
infected 2-year-old horses, ELISA-positive IgG(T) titers lasted up to 5 
months after anthelminthic treatment (Nielsen et al, 2015). In foals, positive 
ELISA values were not obtained until 3-5 months of age, indicating a 
protective role of maternal antibodies (Nielsen et al, 2014).  
 
Except for its potential in diagnostics, the immunogenicity of SvSXP 
makes it an interesting candidate to explore as a vaccine antigen. Within this 
thesis project, studies on immunomodulatory effects of the recombinant 
SvSXP protein are initiated (Addendum) along with studies on a novel 
saponin adjuvant formulation.  
 
2.3 Saponin adjuvants  
Adjuvants are components capable of enhancing and/or shaping antigen-
specific immune responses. Traditionally, vaccines have been composed of 
live attenuated or inactivated microorganisms, which by their heterogeneous 
structure naturally contain both antigen epitopes and multiple PAMPs that 
activate the immune system. However, many modern vaccines built on 
purified protein antigens lack these inherent adjuvant properties, making 
them less immunogenic. Therefore, protein or subunit vaccines need to be 
formulated with an adjuvant to induce an immune response that is potent 
enough to give a long-lasting protection (Reed et al, 2013). Except for 
strengthening the immunogenicity of an antigen, adjuvants can also be used 
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to broaden the immune profile, e.g. against viruses with high antigenic drift, 
or to counteract undesirable immune modulatory capacities, e.g. by parasite 
antigens (Reed et al, 2013; Zawawi & Else 2020).  
 
In veterinary medicine, several types of vaccine adjuvants are used. These 
includes aluminium salts, emulsions, carbomers, liposomes and immune 
stimulating complexes (ISCOMs), that all have different compositions, 
shapes and mode of actions. Some mainly serve as delivery agents (e.g. 
emulsions) while others also have immune stimulatory properties (e.g. 
ISCOMs). In some vaccines, adjuvants are combined with PRR agonists that, 
through induction of cytokines, help guide the immune response in a desired 
direction (Reed et al, 2013; Burakova et al, 2017). In the present thesis, the 
immunomodulatory effects of a novel particulate adjuvant referred to as 
“G3” was evaluated in vitro using eqPBMC. The cytokine inducing capacity 
of G3, alone or together with TLR-agonists or S. vulgaris larvae, was 
assessed using qPCR and ELISA (paper I and II). The G3 adjuvant is a 
descendant to the ISCOMs, which is why I will give a brief description of 
ISCOMs as well as G3.  
 
2.3.1 ISCOMs 
The original ISCOM consisted of purified Quillaja saponin (Quil A), 
cholesterol, phospholipids and viral envelope proteins that were formulated 
into three-dimensional 40 nm cage-like structures (Morein et al, 1984). This 
composition was one of the first vaccine formulations that delivered a 
subunit protein antigen to the cytosol with subsequent induction of CTLs 
(Jones et al, 1988; Takahashi et al, 1990). Some years later, it was 
demonstrated that the antigen does not need to be physically integrated in the 
ISCOM particle but can simply be mixed with the ISCOM-Matrix before 
administration (Lövgren-Bengtsson & Sjölander, 1996). The immune 
modulatory capacity of the ISCOM-Matrix was fine-tuned by varying the 
ratios of the purified saponin subfractions QHA and QHC generating 
MatrixA and MatrixC, respectively, and was manufactured as Matrix-MTM 
by Isconova AB, Uppsala. The combination of these immune-stimulatory 
components with a structure and size optimal for antigen delivery is known 
to induce a balanced Th1/Th2 response with long-lasting antibody 
production (Lövgren Bengtsson et al., 2011). Matrix-M is currently used in 
35 
a number of veterinary vaccines, including the equine Influenza vaccine 
(Equilis® Prequenza), and in the recently licensed vaccine against Strangles 
(Strangvac) from Intervacc AB, Stockholm.  
 
The adjuvant technology of Matrix-M is today hold by the US company 
Novavax (https://www.novavax.com/our-unique-technology#matrix-m-
adjuvant-technology) and applied in phase 3 studies of experimental 
vaccines against seasonal influenza, Respiratory Syncytial Virus and 
Coronavirus (https://www.novavax.com/our-pipeline). The Swedish 
government has recently signed a pre-purchase agreement with Novavax for 
2.2 million doses of their subunit COVID19 vaccine (NVX-CoV2373).  
 
A later adaptation of the ISCOM-technology is the “third generation 
formula”, here referred to as the G3 adjuvant. The G3 adjuvant has been 
supplied by MoreinX AB (Uppsala, Sweden) as Adjuvaq-V100TM but is now 
licensed to Brenntag Biosector A/S (Frederikssund, Denmark) that has 
marketed the product as NanoQuil® (Croda Denmark A/S, Frederiksund, 
Denmark). The G3 adjuvant formula resembles that of ISCOMs but differ in 
that it lacks phospholipids, which makes it easy to produce at a lower cost. 
The G3 nanoparticle is around 20 nm and has a high bioavailability that 
makes it useful for both oral and parental administration (Patent no. WO 
2013/051994). The G3 formula allows for incorporation of other immune 
stimulating molecules making it possible to “tailor-make” the vaccine 
formula to induce a desired immune response. This versatility was 
demonstrated by incorporation of a diterpene in the G3 formula, which 
enhanced and broadened the immune response to H1N1 influenza virus 
strains in mice (van de Sandt et al, 2014). Immunization trials in mice 
combining influenza virus antigens with either Adjuvaq-V100 or aluminum 
hydroxide resulted in comparable levels of antigen specific IgG1 (Th2 
associated subclass) but substantially higher level of antigen specific IgG2a 
(Th1 associated subclass) compared to alum (Hjertner et al, 2018a). A similar 
Th1 profile was recorded in cultures of porcine PBMCs after in vitro 




2.4 Modelling the equine intestine   
 
To allow in vitro studies of helminth antigens in combination with adjuvant 
formulations, improved culture systems reflecting the natural route of 
infection are urgently needed. At present, there is a lack of such in vitro/ex 
vivo models that can more closely replicate the interactions of parasites with 
its host at mucosal surfaces. In this context, stem cell-derived organoid 
cultures has emerged as a new ex vivo tool that can potentially be used to 
study host-parasite interactions (Duque-Correa et al, 2020). In addition, 
methods to co-culture immune cells with organoid cells are starting to 
emerge (Noel et al, 2017; Spalinger et al, 2020; Staab et al, 2020). In the 
present thesis, I have used equine intestinal organoids (paper III) to study 
reactions to the G3 adjuvant, TLR-agonists and preparations of S. vulgaris 
larvae ex vivo.  
 
2.4.1 The equine intestine 
Compared to other herbivore species, the horse’s GI tract is unique by its 
highly developed large hindgut. The major function of the horse’s colon and 
caecum is to ferment dietary fibers from forage, which is dependent on an 
active and well-functioning microflora with fibrolytic activity (Costa & 
Weese, 2012). External factors such as GI nematode infection, dietary 
changes or antibiotic treatment can lead to microbial dysbiosis (Peachey et 
al, 2019; Collinet et al, 2021a, 2021b) likely affecting the local immune 
response. For example, treatment with a broad-spectrum antibiotic resulted 
in loss of commensals and bloom of potential pathobionts affecting immune 
homeostasis as shown by increased concentrations of sIgA in feces and 
decreased TNF-α levels in serum samples (Collinet et al, 2021a).  
 
The intestinal epithelium in most species express a variety of PRRs 
enabling recognition of both commensal and pathogenic microorganisms 
(Andrews et al, 2018). However, studies on the expression of PRRs in the 
equine intestine is limited (Vendrig & Fink-Gremmels, 2012; Werners & 
Bryant, 2012). Expression of TLR4, along with the co-receptors MD-2 and 
CD14 has been tested and confirmed in tissue sections from equine ileum, 
dorsal colon and rectum (Fossum et al, 2012; Olofsson et al, 2015). In the 
same study, cytokine expression of IL-12p40, IL-17A and IL-23p19 was 
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recorded in seven tissue sections of the equine intestine, from duodenum to 
rectum, as well as in rectum biopsies from both healthy horses and horses 
with clinical signs of equine inflammatory bowel disease (Hjertner et al, 
2013; Olofsson et al, 2015). Furthermore, the cytokine expression patterns 
in the equine intestinal mucosa at cyathostomin infection has been evaluated 
in tissue sections from the large intestine (Davidson et al, 2002, 2005; Steuer 
et al, 2020).  
 
2.4.2 The intestinal epithelium 
The lack of equine specific reagents has limited detection of different cell 
lineages present in the equine small and large intestine. However, each 
known type of epithelial cell in the small intestine has also been identified in 
equine intestinal tissue using cross-reactive antibodies or transmission 
electron microscopic imaging (Gonzales et al, 2015).  
 
The intestinal mucosal surface is composed of a single layer of columnar 
epithelial cells overlain by a mucus layer that physically separates the 
epithelium from direct contact with the microbiota. The epithelial cells are 
linked by tight junctions, adherence junctions and desmosomes that regulate 
barrier integrity and permeability. Most cells of the intestinal epithelium are 
involved in water and nutrient absorption but some are also important for 
immune regulation. The epithelium of the small intestine contains regular 
small cavities, called crypts of Lieberkühn, which contains stem cells 
interspersed by Paneth cells. The small intestine further contains villi that 
protrude from the epithelia to maximize absorption of nutrients. As the stem 
cells divide, progenitor cells progress through the crypt-villus axis and 
eventually differentiate to either absorptive enterocytes (dominant cell type) 
or to more specialized cell types, such as enteroendocrine-, goblet- or tuft 
cells (Gonzales et al, 2015). When they reach the tip of the villi, normally 
after 5-6 days, the cells go into a form of detachment-induced cell death 
referred to as anoikis (Figure 2). 
 
The epithelial turnover requires a balanced regulation between cellular 
proliferation and cellular losses to remain in homeostasis. When the 
epithelial integrity is challenged, e.g. by invading parasites, the rate of 
epithelial turnover can however change. In fact, most GI helminths disrupts 
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the epithelial barrier at some point during infection by mechanisms not well 
understood for most helminth species. As a result, the intestinal integrity 
becomes impaired causing an increase in intestinal permeability. To 
compensate, the speed of epithelial turnover often increases at helminth 
infection (McKay et al, 2017).   
 
2.4.3 Intestinal organoids 
Organoids are stem cell-derived three-dimensional cultures that resembles 
the architecture and cell composition of the organ of origin. Small intestinal 
organoids, referred to as enteroids, were first generated from murine crypts 
cultured in the presence of intestinal niche growth factors supported by 
extracellular matrix components (Sato et al, 2009). Since then, the enteroid 
technology has become standardized in mice and humans, and are now 
beginning to be explored for veterinary species, including the horse 
(Bartfield, 2016; Steiler Stewart et al, 2017; Kar et al, 2021). The culture 
system utilizes the inherent ability of the intestinal epithelia to self-renew 
and differentiate to specialized intestinal cell types. Accordingly, enteroids 
contain most cell lineages of the small intestine, such as stem cells, 
enterocytes, enteroendocrine cells, goblet cells, paneth cells and tuft cells, 
reflecting important aspects of the original architecture and function of the 
intestinal epithelia (Figure 2). Enteroid cultures have a wide range of 
applications and have been used to model gastrointestinal infections, gut-




Figure 2. Illustration of the epithelium in the equine small intestine and enteroid cultures.
The composition of cell lineages and their distribution along the epithelium of the small 
intestine are reflected in the equine enteroids. 
One limitation with the 3D enteroid model is its enclosed morphology, 
with the apical surface of the epithelia facing inwards and the basolateral 
surface facing outwards. This makes it difficult to access the enteroid lumen 
and expose the apical surface to experimental treatments. This is especially 
problematic when it comes to large complex helminths that, depending on 
the species and life cycle stage, simply cannot fit into the 3D enteroid. 
However, there are several strategies to gain access to the apical surface of 
the epithelum, e.g. by microinjection, “inside-out enteroids” or enteroid-
derived 2D monolayers, as recently demonstrated in studies of 
enteropathogenic bacteria (Co et al, 2019; Geiser et al, 2021; Samperio 
Ventayol et al, 2021). In fact, most infection studies using enteroids are on 
bacteria, viruses or protozoa, and very little is published on helminths 
(Duque-Correa et al, 2020). A few studies have used enteroids to study 
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epithelial responses to ES products (Eichenberger et al, 2018; Chandra et al, 
2019; Luo et al, 2019) and some studies have indirectly investigated the 
effect of helminth-induced immune responses on the intestinal epithelium. 
For example, the role of IL-13 in tuft cell activation was partly demonstrated 
in murine enteroids (von Moltke et al, 2016; Luo et al, 2019). To my 
knowledge, there is currently only one paper describing direct interactions of 
living helminths with enteroid cells (Smith et al, 2021). However, new 
adaptations of enteroid culture methods such as enteroid-derived 2D 
monolayers or inside-out enteroids open up for future studies of host-
helminth interactions. In addition, methods to co-culture enteroid cells with 
immune cells allows for studies of cross-communication between different 
cell populations adding on new dimensions to the enteroid model system 
(Noel et al, 2017; Spalinger et al, 2020; Staab et al, 2020).  
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To develop a vaccine against S. vulgaris, it is essential to understand how the 
infective stage larvae interacts with its host. To balance possible 
immunomodulatory capabilities of helminth antigens, it might be necessary 
to define appropriate adjuvant formulations. The overall aim of this thesis 
was therefore to set up ex vivo models and establish methods to study 
immune responses against S. vulgaris in the horse.  
 
 
The specific objectives were to: 
 
- Establish methods to generate defined larval stages of S. vulgaris 
- Map the cytokine response to these larval stages 
- Map the cytokine response to a recombinant protein from S. 
vulgaris (SvSXP) 
- Evaluate innate immune responses to the G3 adjuvant 
- Establish methods to generate cultures of equine enteroids and 
enteroid-derived 2D monolayers  
- Apply these enteroid models to study host-parasite interactions at 
the site of infection 
- Study how the infective stage of S. vulgaris affects the intestinal 
epithelium in enteroid-derived 2D monolayers, alone or in co-




3. Aim and objectives  
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This thesis was built upon ex vivo experiments using larval cultures and 
equine primary cells. Here, I will comment on the methods used. For detailed 
descriptions, I refer to the individual papers I-III.   
 
4.1 Blood donor horses  
Blood was collected from Swedish warmblood horses (Paper I, n = 12; Paper 
II, n =11 and Addendum, n = 10) housed at the Department of Clinical 
Sciences at SLU or in private stables. These mares and geldings, aged 
between 5 and 21 years, were regularly vaccinated against tetanus and 
influenza and regarded as healthy by their owners. Parasite diagnostics for 
all horses were performed every spring. This included tapeworm and 
strongyle egg counts (EPG) followed by larval culture or qPCR for detection 
of S. vulgaris. Horses with an EPG >200 and/or confirmed as S. vulgaris 
positive were treated with ivermectin. The blood sampling was approved by 
the Ethical Committee for Animal Experiments, Uppsala, Sweden 
(C.214813/14; 5.8.18-15533/2018 and 5.8.18-08784/2020). 
 
4.2 Parasite material 
Fecal samples collected from private horses with a diagnosed S. vulgaris 
infection were kindly provided from other projects on S. vulgaris (Tydén et 
al, 2019; Hedberg Alm et al, 2020). Since S. vulgaris almost always occur in 
co-infection with cyathostomins, horses with a high proportion of S. vulgaris 
as determined by microscopy or diagnostic qPCR were selected. From these 
4. Comments on material and methods 
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fecal samples, third stage larvae (L3) were generated by coproculture and 
collected using the inverted petri-dish method that is routinely used at 
diagnosing equine strongyles (Van Wyk & Mayhew, 2013). All S. vulgaris 
L3s were identified morphologically according to Bevilaqua et al (1993). In 
addition, S. vulgaris DNA was confirmed by qPCR analysis of samples 
collected from the same larval batches (National Veterinary Institute, 
Uppsala, Sweden). To obtain single species samples, S. vulgaris L3s were 
collected under the microscope using a 10 μL pipette. The L3s were stored 
in tap water at +4 ⁰C until use. In our hands, the cyathostomin and S. vulgaris 
L3s could be preserved in water for up to 6 and 10 months, respectively, as 
the L3s at this stage still are covered by their protective L2 cuticle and relying 
on stored nutrients.  
4.3 S. vulgaris larval cultures  
To study immune reactions to the early larval stages of S. vulgaris, a protocol 
for molting of S. vulgaris from L3 to L4 (Chapman et al, 1994) was adopted 
and slightly modified. Since the L3s were generated from fecal cultures, the 
larvae were decontaminated by incubation in PBS containing antibiotics, 
antifungals and the endotoxin-neutralizing agent polymyxin B. Bacterial 
cultures and endotoxin tests showed no microbial growth and less than 0.70 
IU/mL endotoxin after 24 h decontamination. Despite the low level of 
endotoxin in the L3 preparations, parallel cultures with PBMCs exposed to 
1 IU endotoxin/mL were included as controls (paper I).  
 
When indicated, the L2 cuticle was exsheated from the L3s by incubation 
in sodium hypochlorite (detailed in Paper I). Without its protective L2 
cuticle, the exsheated L3s (exL3s) became more fragile and sensitive to the 
environment and care was taken to ensure that the exL3s were put into 
culture immediately after exsheatment. The exL3s were cultured in an 
optimized medium “cKW2” known to trigger L3 development and molting 
to the L4 stage (Chapman et al, 1994). As noted by Farrar & Klei (1985), the 
morphology of the late exL3 is almost identical to the early L4, making it 
difficult to distinguish between the two larval stages before and after 
molting. However, all larvae molted almost simultaneously at day 5 of 
culture. The cuticle release progressed over several hours with cuticle casts 
remaining visible in the culture medium for at least 24 h after shedding. 
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Therefore, molted larvae devoid of their L2 and L3 cuticle are in the present 
thesis referred to as “S. vulgaris L4” according to previous definitions (Farrar 
& Klei, 1985; Chapman et al, 1994; Monahan et al, 1994). The procedure for 
generation of L3, exL3 and L4 stages of S. vulgaris is illustrated in figure 3.
  
    
Figure 3. Scheme for generating different larval stages of S. vulgaris. L3 larvae were 
generated from fecal cultures (A) and decontaminated in PBS containing antimicrobials 
and antimycotics (B). Decontaminated L3s were exsheated in hypochlorite to obtain 
exL3s (C). ExL3s were cultured in cKW2 medium to trigger molting to L4 (D).   
To evaluate the cytokine response to surface antigens on the three larval 
stages of S. vulgaris, a procedure for attenuation by UV irradiation of larvae 
was set up (Paper I). Due to the limited access to S. vulgaris larvae, 
cyathostomin L3s were initially used to optimize these conditions (time and 
dose as specified in Paper I) giving intact but non-motile larvae. These 
conditions were then applied to the S. vulgaris L3, exL3 and L4s 
preparations. 
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4.4 Cultures of equine PBMC 
4.4.1 Culture conditions 
Cytokine induction by the G3 adjuvant, TLR agonists and attenuated S. 
vulgaris larvae (papers I and II) were studied in cultures of eqPBMCs. In 
addition, eqPBMCs were used in co-culture experiments with enteroid 
derived 2D monolayers cultured in transwell inserts (see 4.5.5). Before 
seeding the eqPBMcs, cell viability was estimated by counting in Trypan 
blue, and confirmed to be >95 %. Occasional staining with Türks reagent 
showed a minor contamination with erythrocytes. Cells to be harvested for 
transcriptional analysis (qPCR) were cultured in 6-well plates at a 
concentration of 5-10 x 106 cells/mL and cells used for protein quantification 
(ELISA) were cultured in round bottomed 96-well plates at a concentration 
of 4 x 106 cells/mL in agreement with previous studies using eqPBMCs 
(Wattrang et al, 2005, 2012; Olofsson et al, 2016). The periods of stimulation 
for eqPBMCs used in transcriptional studies and for protein quantification 
were 18-20 h and 48 h, respectively. 
4.4.2 Cell induction experiments 
Based on serial dilutions of the G3 adjuvant (Paper II), a concentration of 5 
μg G3/mL was used throughout the Thesis and Addendum. To study effects 
of G3 in combination with other immune stimulatory compounds, the TLR5 
agonist FliC and TLR2/1 agonist Pam3CSK4 were chosen. In other animal 
species, FliC and Pam3CSK4 enhance the immunogenicity of viral, bacterial 
and protozoan vaccines (Mizel & Bates, 2010; Jayakumar et al, 2011; 
Caproni et al, 2012). To date, only a few studies are available on effects of 
FliC and Pam3CSK4 in equine cells (Figueiredo et al, 2009; Leise et al 2010; 
Irvine et al, 2013; Kwon et al, 2011).  
 
To study immune reactions to strongyle larvae, eqPBMC were exposed 
to UV attenuated S. vulgaris L3, exL3 and L4 as well as to cyathostomin 
L3s. The polysaccharide chitin, known to be abundant in parasitic 
nematodes, and suggested to play a key role in recruitment and activation of 
innate immune cells (Perrigoue et al, 2008), was included as a control (Paper 
I).  
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4.4.3 Set up of intracellular cytokine staining and cell surface 
phenotypic characterization of equine IFN-  producing cells 
(Addendum) 
Intracellular staining for IFN-γ was performed on eqPBMC cultured in the 
presence of 5 μg G3/mL, 0.5 μg Pam3CSK4/mL or in the combination of G3 
and Pam3CSK4. EqPBMC grown in medium alone or in medium with 0.05 
μg PMA/mL and 1 μg Ionomycin/mL were used as negative and positive 
controls, respectively. For each type of culture, approximately 1.5 x 106 
eqPBMCs/mL were grown in 2 mL RPMI without phenol-red in non-stick 
tubes at culture conditions previously described (Papers I and II). Initially, 
the total culture time was varied from 24-48 h and two secretion blockers 
(Brefeldin A and Monensin) as well as the time for their inclusion was tested. 
From these experiments the conditions for the final phenotypic 
characterization of IFN-γ producing cells was determined as specified below 
and the positive control was changed to ConA (2.5 μg/mL) to facilitate the 
gating procedures.  
The cultures were first incubated for 12 h at 37 ⁰ C and thereafter 
stimulated with 5 μg G3/mL and Pam3CSK4 0.5 μg/mL (G3+Pam), 2.5 
μg/mL ConA or in plain growth medium for another 12 h. The secretion 
blocker Brefeldin A was included the whole stimulation time. After 
stimulation, the PBMCs were washed in staining buffer consisting of PBS 
without Mg2+ and Ca2+, 1 % fetal calf serum (FCS), and 0.09 % sodium azide 
and stained with LIVE/DEAD Green (fixable dead cell stain kit, Invitrogen) 
and monoclonal antibodies to equine CD4, CD8α and CD8β (Table 1). 
Fixation and intracellular staining for equine IFN-γ (Table 1) were 
subsequently performed using the BD Cytofix/Cytoperm Plus 
Fixation/Permeabilization Kit according to the manufacturer’s instructions.  
 
Flow cytometry was performed using a BD FACSVerse™ (BD 
Biosciences), equipped with 488 nm blue, 633 nm red and 405 nm violet 
lasers and results were analyzed using the FACSDiva (BD Biosciences) 
software. Single-stained compensation controls and fluorescence minus one 
(FMO) negative controls were included in the assays. Samples were recorded 
for 5 min at a low flow rate. Titrations of all antibodies were performed to 




Table 1. Fluourchrome conjugated antibodies for phenotypic identification of equine 
IFN-γ producing cells  
Antibody Clone  Specificity Fluorochrome Company 




CD8α-RPE CVS21 α-chain of equine CD8 R-phycoerythrinb BioRad 
CD8β-
PerCPCy5.5 




IFN-γ-PF647P MT116 Equine IFN-γ PromoFluor-647Pb Mabtech 
a Fluorochrome conjugated using Lightning-Link® conjugation kits (Abcam) according to the 
manufacturer’s protocol. 
b Fluorochrome conjugated by manufacturer. 
 
4.4.4 SvSXP 
A recombinant S. vulgaris protein SvSXP expressed in E. coli was kindly 
provided by Assoc Prof Martin Nielsen at Gluck Equine Research Center, 
University of Kentucky, USA. Before use, the SvSXP protein was purified 
from endotoxin using Pierce high capacity endotoxin removal resin and 
measured using the Pierce LAL chromogenic endotoxin quantification kit 
(Life Technologies) according to the manufacturer’s instruction. The 
purified SvSXP protein was thereafter used as re-call antigen in cultures of 
eqPBMC obtained from horses with a known history of previous exposure 
to S. vulgaris and in equine enteroid cultures. Various concentrations of 
recombinant SvSXP were co-cultured with eqPBMC in 6-well plates at the 
same conditions as described in Paper I and II. The cytokine inducing 
concentration of SvSXP was tested in four separate experiments using either 
0.25, 0.5 and 0.75 μg SvSXP/mL or 1.0, 1.5 and 2.0 μg SvSXP/mL. The 
horses were categorized based on their records for the last four years 
regarding parasite burden (EPG and S. vulgaris detection as described in 4.1) 
provided by the horse owners. The “low exposure” group includes horses (n 
= 3) with only negative test results for S. vulgaris, the “previous confirmed” 
group includes horses (n = 5) previously tested positive one or multiple times 
but negative for S. vulgaris at the time of blood sampling, and the 
“confirmed” group includes horses (n = 3) positive for S. vulgaris at the time 
of sampling.  
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After 20 h exposure to SvSXP in PBMC obtained from horses in the 
various groups, the eqPBMC were analyzed for their expression of cytokine 
genes (IFN-γ, IL-1β, IL-2, IL-4, IL-5, IL-8, IL-9, IL-10, IL-13, IL-17A, IL-
33 and TSLP) using methods described in paper I and II. This data set is far 
from complete, but preliminary results are given in Addendum (5.3.2) and 
referred to in the Discussion.  
 
4.5 Enteroids 
4.5.1 Generation and culture of equine enteroids 
Equine enteroids were generated from crypts isolated from equine mid-
jejunum (Figure 4). To avoid excessive cell death, tissue sections were 
immediately put in ice-cold PBS containing antimicrobials, antifungals and 
an apoptosis blocker (Rho kinase inhibitor Y27632) and processed within 
one hour of collection. Isolation of crypts and the subsequent culture were 
performed in accordance with a previously published protocol for equine 
enteroids (Steiler Stewart et al, 2018).  
 
To enable three-dimensional growth, the crypts were cultured in Matrigel, 
which is a medium generated from mouse sarcoma cells containing 
extracellular matrix components such as laminin, collagen type IV, 
entactin/nidogen and heparin sulfate proteoglycans as well as a variety of 
growth factors (Kleinman et al, 1986; Kleinman & Martin, 2005). In the 
equine enteroids however, a Matrigel with low concentrations of growth 
factors (GFR membrane matrix, Corning) was used to generate a more 
defined culture medium. The growth factors included in the equine enteroid 
medium were Wnt3a, R-spondin, Noggin, EGF and CHIR99021 that 
stimulates the Wnt signaling pathway essential for cell proliferation and 
differentiation of intestinal epithelial cells. In addition, the Rho kinase 
inhibitor Y-27632 prevents anoikis induced cell death, the p38 inhibitor 
SB202190 prevents apoptosis as well as enhance proliferation and 
differentiation, and the TGF-β receptor I inhibitor LY2157299 reduce 
apoptosis and promotes stem cell survival (Merker et al, 2016). Together, 






Figure 4. Equine enteroid after seven days of culture. 
 
4.5.2 Establishment of enteroid-derived 2D monolayer cultures 
To enable easy access to the apical surface of the epithelium, a protocol for 
two-dimensional cultures of porcine enteroids was adapted (van der Hee et 
al, 2018). To prevent detachment-induced anoikis, the wash medium was 
supplemented with Y-27632. The cell viability after washing was between 
60-90 % in the different experiments, estimated by Trypan blue staining. The 
2D monolayers were cultured on 24-well flat-bottomed culture plates or on 
12-well transwell inserts. To facilitate cell attachment and monolayer 
growth, plates and inserts were pre-coated with Matrigel as previously 
elaborated in several studies (e.g. Liu et al, 2018; van der Hee et al, 2018; 
Altay et al, 2019).  
 
The transwell culture system is built up by an upper and lower 
compartment separated by a permeable membrane for culture of epithelial 
monolayers (Figure 5b). In the following text I will refer to the upper 
compartment as the “apical surface” and the lower compartment as the 
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“basolateral surface”.  In these cultures, transepithelial electrical resistance 
(TEER) was monitored as a measurement of the barrier integrity.  
4.5.3 Exposure of enteroid monolayers to microbial mimics 
The same TLR-agonists used to stimulate eqPBMC (Paper II) were used to 
assess the functionality of the equine 2D monolayers (Paper III). The TLR 
agonists used were a recombinant flagellin protein from Salmonella 
Typhimurium, FliC (TLR5), lipopolysaccharide (LPS) from E. coli O111:B4 
(TLR4), the synthetic lipopeptide Pam3CSK4 that mimics the acetylated 
aminoterminus of bacterial lipopeptides (TLR2/1) and Poly I:C, a double 
stranded RNA analogue (TLR3) mimicking viral infections. Together, these 
TLR agonists represent an array of microorganisms supposed to trigger 
immune-regulatory reactions in the intestinal epithelia (Andrews et al, 2018) 
and were thus considered appropriate to test the responsiveness of the equine 
monolayers. 
4.5.4 Exposure of enteroid monolayers to S. vulgaris in the presence 
of Th polarizing cytokines  
To study interactions of S. vulgaris with the intestinal epithelium under the 
influence of Th polarizing cytokines, the basolateral surface of enteroid 
monolayers cultured on transwell inserts were exposed to IL-4 and IL-13 or 
IFN-γ (equine yeast-derived recombinant proteins, Kingfisher Biotech, Inc). 
After 72 h, approximately 20 living exsheated S. vulgaris L3 larvae were 
added to the apical surface of each well and incubated for another 20 h 
(Figure 5c). As controls, S. vulgaris were added to the apical surface of 
enteroid monolayers not exposed to cytokines and enteroid monolayers were 
exposed to cytokines but not S. vulgaris. In parallel, monolayers cultured in 
plain growth medium were included as controls. All experimental treatments 
were performed in triplicates and pooled at harvest. The methods used for 
transwell culture, cell harvest, RNA isolation, cDNA synthesis and 
transcriptional analysis of cell lineage markers were performed as detailed in 
paper III. Preliminary results from this experiment are given in Addendum 
(5.6) and referred to in the Discussion.    
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4.5.5 Exposure of enteroid monolayers to S. vulgaris in co-culture with 
eqPBMC 
To further expand the equine enteroid 2D model, a co-culture system of 
enteroid monolayers and eqPBMC was set up using transwell inserts (Figure 
5d). Cultures of eqPBMC were established using previously described 
methods (Papers I and II) and incubated overnight in the presence of 5 μg/mL 
G3, 2 μg/mL SvSXP or in plain growth medium. Approximately 2 x 106 
PBMCs were transferred to the basolateral surface of confluent enteroid 
monolayers. These co-cultures were thereafter challenged with 
approximately 20 living exsheated S. vulgaris L3s per well, added to the 
apical surface of the enteroid monolayer. After 20 h incubation the enteroid 
monolayers and the eqPBMCs were harvested separately and processed for 
transcriptional analysis of cytokine genes performed as described in papers 
I, II and III. In addition, TEER was measured (described in Paper I) in 
enteroid monolayers after 20 h exposure to S. vulgaris exL3 or G3. 
















Figure 5. Scheme for enteroid monolayer experiments. Equine enteroids (A) were 
dissociated to single cells and cultured as monolayers on transwell inserts (B). S. vulgaris 
exL3s were added to the apical surface of enteroid monolayers cultured in the presence 
of Th polarizing cytokines at the basolateral surface (C) or in co-culture with eqPBMC 
(D).  
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4.6 Gene expression analysis 
4.6.1 RNA isolation and quality control 
RNA from the PBMC and enteroid cultures was extracted using a 
combination of the Trizol reagent and the column-based E.Z.N.A Total RNA 
Kit as previously described by Wikström et al (2011). By using spin 
columns, the risk of Trizol contamination is reduced which can otherwise 
impact RNA quantification on spectrophotometers and interfere with the 
subsequent cDNA synthesis. However, for some of the samples with low 
RNA yield, the 260/280 ratios, measured by a Nanodrop spectrophotometer, 
were below the recommended interval of 1.8-2.0, indicating the presence of 
contaminants. Despite this, cDNA was successfully synthesized from these 
samples, and showed no discrepancy in the expression of reference genes. In 
addition, the quality of the RNA was estimated in a selection of eqPBMC 
samples (Paper I and II) using capillary gel electrophoresis (Experion). All 
samples tested had an RNA quality index (RQI) ≥9.3 indicating intact RNA 
of good quality.    
4.6.2 Synthesis of cDNA 
To control for genomic DNA contamination, all samples were DNAse 
treated prior to cDNA synthesis. To confirm removal of genomic DNA, an 
assay targeting a product lacking introns was performed on non-reverse 
transcribed control samples as previously described (Hjertner et al, 2013). 
The cDNA synthesis was performed using the GoScript Reverse 
transcription system kit using 1.0 μg RNA per reaction (Paper I). For samples 
with a lower yield, a smaller amount of RNA, between 0.4-1.0 μg, was used 
(Paper II). Regardless, equal amounts of RNA were used within each 
individual horse to facilitate comparisons between treatments.   
4.6.3 Assays for qPCR 
Primer pairs for a panel of equine cytokines, representing Th1, Th2, Th17, 
Treg and Th9 responses, and TLR receptors were used to assess immune 
reactions to experimental treatments in eqPBMCs and enteroid-derived 2D 
monolayers. A gradient qPCR was run to estimate the optimal assay-specific 
annealing temperature and primer concentration for each assay. The assay-
specific efficiency was thereafter estimated by running a serial dilution of 
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reference cDNA. For assays targeting pro-inflammatory cytokines and TLR 
receptors, the reference cDNA was PMA/Ionomycin stimulated eqPBMC. 
For assays targeting interferons, a reference cDNA made from eqPBMC 
stimulated with ODN2216 was used.  The cut-off for an acceptable assay 
was set to >90 <105 % efficiency and r2> 0.9.  
 
The enteroids and enteroid-derived 2D monolayers were characterized by 
their expression of cell lineage markers. A panel of primer pairs for LGR5 
(stem cells), SOX9 (stem and progenitor cells), PCNA (proliferative cells), 
EPCAM (epithelial cells), LYZ (paneth cells), CGA (enteroendocrine cells), 
MUC2 (goblet cells) and DCLK1 (tuft cells) were tested and optimized for 
their assay specific annealing temperature and primer concentration using 
qPCR. By running serial dilutions of reference cDNA made from sections of 
equine intestinal segments (Hjertner et al, 2013), all assays except LGR5 and 
DCLK1 were optimized with an efficiency >90 % and r2>0.9. The LGR5 
gene is exclusively expressed by intestinal stem cells and is therefore an 
important marker for characterization of enteroids (Sato et al, 2009). 
However, the basal LGR5 expression in the equine enteroids as well as in 
the reference cDNA was very low, hindering efficiency estimations by serial 
dilution. The tuft cell marker DCLK1 was also expressed at low levels in 
both enteroids and reference cDNA, complicating efficiency estimations. 
Therefore, annealing temperature and primer concentration for DCLK1 were 
determined by gradient qPCR analysis only.  
4.6.4 Normalization of gene expression 
To enable normalization of the gene expression data, a variety of reference 
genes were evaluated for their expression stability (geNorm software, 
qBasePLUS) using a representative collection of samples from eqPBMC and 
equine enteroids. Ranked by a gene stability parameter and a coefficient of 
variation, RPL32 and SDHA were selected for normalization of eqPBMC 
samples whereas GAPDH, HPRT and SDHA were selected for 
normalization of enteroid material. This corresponds with previous data on 
the equine intestine, where the same set of reference genes were identified as 






5.1 Cytokine responses to different larval stages of S. 
vulgaris (Paper I) 
At invasion of the intestinal mucosa and during migration in the mesenteric 
arterial system, the S. vulgaris larvae undergo several molts. To study how 
these different larval stages influence the cytokine response at an early phase 
of infection, methods for generating defined larval stages of S. vulgaris were 
established and the preparations tested in cultures of eqPBMC (Paper I). 
Procedures for decontamination, culture and attenuation by UV-irradiation 
were elaborated using L3 stage larvae of the related species cyathostomins 
and thereafter applied to S. vulgaris.  
 
When tested in cultures of eqPBMC, L3s from both cyathostomins and S. 
vulgaris induced gene expression for the Th2 polarizing cytokines IL-4, IL-
5, and IL-13 but not for IL-1β, IL-6, IL-8, IL-9, IL-10, IL-12p40, IL-17A, 
IL-23p19 or TGF-β. Molting of S. vulgaris from the L3 to L4 stage did not 
affect the expression of IL-4 and IL-13 but was accompanied by a shift to 
high expression of IL-5, IL-9 and TSLP. Unexpectedly, the L4s also induced 
high levels of IFN-γ indicating a shift from a Th2 to Th1 response (Figure 
6). Thus, the L4 stage appears to induce a different cytokine profile compared 
to earlier larval stages.  
5. Results  
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Figure 6. Relative expression of IFN-γ, IL-4, IL-5, IL-9, IL-13 and TSLP in eqPBMC after 
exposure to defined larval stages of S. vulgaris. The eqPBMCs were cultured in the presence 
of UV irradiated L3, exsheated L3 or L4 of S. vulgaris followed by transcriptional analysis of 
cytokine genes. The figure is adapted from Paper I.  
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5.2 Cytokine responses to the G3 adjuvant (Paper I, II) 
The immune stimulatory capacity of the G3 adjuvant was studied in cultures 
of eqPBMC (Paper II). Transcriptional analysis of cytokine genes showed 
that G3 alone induces a response mainly characterized by up-regulation of 
the pro-inflammatory cytokines IL-1β, IL-6, IL-8 and the Th1-associated 
cytokines IFN-γ, IL-12p40 and IL-23p19. The Th2 associated cytokines IL-
4 and IL-13 as well as the Treg cytokines IL-10 and TGF-β were in general 
not differentially expressed (Paper II). This immune profile, summarized in 
Figure 7 is coherent with the results found in Paper I, where eqPBMC were 
stimulated with 5 μg G3/mL, alone or in combination with strongyle larvae.   
 
 
Figure 7. The cytokine profile induced by the G3 adjuvant (5μg/mL) in cultures of 
eqPBMC. The figure shows gene expression data summarized from Paper I and II.  
 
5.3 Cytokine responses to the G3 adjuvant in combination 
with TLR-agonists or strongyle larvae (Paper I, II) 
Effects of G3 on the cytokine response to microbial PAMPs was studied in 
eqPBMC exposed to G3 in combination with TLR-ligands (Paper II) or UV-
attenuated S. vulgaris or cyathostomin L3s (Paper I). Both the TLR2/1 and 
TLR5 agonists Pam3CSK4 and FliC, respectively, induced similar cytokine 
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profiles with up-regulation of the genes encoding IL-1β, IL-6, IL-8 and IL-
10, but at different magnitudes. This response was partly counteracted by the 
G3 adjuvant, most evidently by reducing the FliC and Pam3CSK4 induced 
production of IL-10 (Fig. 4, Paper II). Interestingly, G3 seemed to act in 
synergy with Pam3CSK4 by enhancing the production of IFN-γ whereas G3 
combined with FliC increased the gene expression of IL-8 (Fig 3, Paper II). 
In agreement, the Th2 polarizing effect by S. vulgaris and cyathostomin L3s, 
was counteracted by the G3 adjuvant that reduced the expression of IL-4, IL-
5 and IL-10 while in parallel enhanced the expression of IFN-γ (Fig. 4, Paper 
I). Thus, the G3 adjuvant appears to promote a Th1 polarizing immune 
response in eqPBMC, both by favouring IFN-γ production and by reducing 
production of IL-10 induced by co-delivered TLR agonists or UV-attenuated 
strongyle larvae. 
5.3.1 Phenotypic characterization of IFN-γ producing cells 
(Addendum) 
Both the original ISCOM formulation and the ISCOM-Matrix have been 
shown to induce IFN-γ producing cells in horses vaccinated against equine 
influenza virus (Paillot et al, 2008; Paillot & Prowse, 2012). Therefore, 
attempts were made to characterize the cells that produced IFN-γ in response 
to the G3 adjuvant and/or Pam3CSK4 explaining the indicated synergy effect 
(Fig.4, Paper II). As expected, a great individual variation was observed 
between horses in their response to PMA/Ionomycin (ranging from 10.6 to 
37.7 % IFN-γ+ cells, n = 8). All horses showed a low, but varied spontaneous 
IFN-γ production (0.14 ± 0.11 % IFN-γ+ cells, n = 8). The proportion of cells 
detected as IFN-γ positive also varied within groups after incubation in G3 
(0.27± 0.18%, n=8), Pam3CSK4 (0.54 ± 0.38 %, n = 7) or the combination 
of G3 and Pam3CSK4 (0.72 ± 0.41 %, n= 8). Thus, this preliminary data do 
not support any synergistic effect between G3 and Pam3CSK4. Instead, it 
appears that G3 and Pam3CSK4 initiates IFN-γ production in two different 
or partly overlapping cell populations.  
 
In order to further characterize the cells producing IFN-γ in response to 
the combination of G3 + Pam3CSK4, a panel of antibodies detecting equine 
CD4, CD8α, CD8β and intracellular production of IFN-γ were tested using 
multicolor flow cytometry (Figure 8). As controls, eqPBMC cultured in plain 
growth medium or stimulated with ConA were used. Preliminary results 
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from one blood donor horse show that CD4, CD8α and CD8β are expressed 
at similar levels in ConA, G3+Pam3CSK4 and non-stimulated cells (Figure 
8F). Stimulation with ConA increased the fraction of IFN-γ producing cells 
from 0.02 % in the medium control to 2.94 % in ConA stimulated cells 
(Figure 8G-H). A large proportion these ( ̴ 66 %) were CD4+ cells (Figure 
8L). Exposure to G3+Pam3CSK4 resulted in a slight increase (0.17 %) in  
IFN-γ producing cells compared to the medium control (Figure 8I). In 
contrast to ConA, a large proportion ( ̴ 65 %) of the G3+Pam3CSK4 
stimulated cells were CD4-, CD8α- and CD8β negative. In addition, the 
fraction of cells positive for CD8α but negative for CD4 and CD8β (thus, 
classified as CD8αα) was larger in G3 + Pam3CSK4 (10%) compared to 
ConA stimulated cells (2 %; Figure 8L). Thus, from these preliminary data 
it appears as a large proportion of the cells that produce IFN-γ in response to 
G3 + Pam3CSK4 are negative for CD4, CD8α and CD8β indicating that 
other cell types than T cells are predominantly activated by this adjuvant 
combination. However, additional experiments are needed to characterize 
these cells. 
  
Figure 8 (figure on next page). Gating strategy for flow cytometry and results from 
phenotypic identification of IFN-γ producing eqPBMC from one healthy blood donor 
horse after 12 h stimulation in cell culture. Identification of CD4+, CD8αβ+ and CD8αα+ 
cells, respectively, on these cells through FSC/SSC characteristics, singlet gating and 
using CD4-PE/Cy7, CD8β-PerCp/Cy5.5, CD8α-PE and IFN-γ-PF647P. From the gate 
excluding debris in initial dot-plot in A gating through FSC-H vs FSC-A was performed 
in B to exclude large aggregates. From this gate, live cells were gated through exclusion 
of events stained with Green dead stain in C. From the live gate CD8β+ cells (i.e. 
CD8αβ+) were identified in D. Subsequently CD4+ and CD8α+ (i.e. CD8αα+) cells were 
identified from the CD8β- cells in E. F shows results phenotyping the whole live cell 
population in PBMC cultures in plain growth medium or in medium with the indicated 
inducers. G, H and I shows gating of IFN-γ+ cells from the whole live PBMC population 
in cultures in plain growth medium in G, stimulated with ConA in H and Stimulated with 
G3+Pam in I. The proportion of IFN-γ+ out of the whole live cell population is indicated 
in the respective dot-plot. From the live IFN-γ gate CD8β+ cells (i.e. CD8αβ+) were 
identified in J. Subsequently CD4+ and CD8α+ cells were identified from the CD8β- 
cells in K. L shows results phenotyping the live IFN-γ+ cells in cultures stimulated with 
the indicated inducers (in medium cultures fewer than 100 IFN-γ+ events were identified 
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and further phenotyping was therefore not meaningful). All dot-plots except G and I 















5.3.2 Cytokine responses to SvSXP (Addendum) 
The cytokine response to the recombinant SvSXP protein was studied in 
cultures of PBMC isolated from horses with an ongoing or known history of 
S. vulgaris infection (description in 4.4.4). The eqPBMCs were stimulated 
with 0.25, 0.5 and 0.75 μg SvSXP/mL or 1.0, 1.5 and 2.0 μg SvSXP/mL for 
20 h followed by transcriptional analysis of cytokine genes. Preliminary data, 
from a yet incomplete set of horses, indicate that the SvSXP protein induce 
expression of the genes encoding IFN-γ, IL-2 and IL-17A in eqPBMC from 
horses in all three groups of horses (Figure 9A-C). Expression of IFN-γ and 
IL-2, but not IL-17A, appeared to be induced in a dose-dependent manner. 
With this limited data set, it was not possible to estimate differences in the 
cytokine expression between the three groups. The genes for IL-1β, IL-4, IL-
8, IL-10, IL-33, TNF-α and TSLP were not differentially expressed whereas 
the genes encoding IL-5 and IL-9 were occasionally slightly up-regulated. 
 
Figure 9. Relative expression of IFN-γ, 
IL-2 and IL-17A in eqPBMC.  
The PBMCs were isolated from horses 
with an ongoing S. vulgaris infection 
(i.e. “confirmed S. vulgaris”, indicated 
by red circles, n = 3), a previous record 
of S. vulgaris infection (i.e. “previous 
confirmed S. vulgaris”, indicated by 
orange circles, n =5) or no previous 
record of S. vulgaris infection (i.e. “low 
exposure”, indicated by green circles, n 
= 3). The eqPBMCs were cultured in the 
presence of either 0.25, 0.5 and 0.75 μg 
SvSXP/mL or 1.0, 1.5 and 2.0 μg 
SvSXP/mL as indicated in the graph.  
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5.4 Generation of equine enteroids and enteroid-derived 
2D monolayers (Paper III) 
Equine enteroid cultures were established from crypts isolated from equine 
mid-jejunum (Paper III). The enteroid cultures could be passaged, frozen and 
thawed multiple times with >80 % recovery. To enable easy access to the 
apical surface of the epithelium, the enteroids were dissociated into single 
cells and seeded on transwell inserts or on standard flat-bottom culture plates 
pre-coated with Matrigel. At a seeding concentration of 4-5 x 104 cells/cm2, 
more than 90 % confluence was reached after three days culture. The 
monolayers remained intact for up to 8 days on the flat-bottomed culture 
plates and up to 13 days on the transwell inserts. TEER analysis of the 
transwell cultures showed that the monolayer integrity was stabilised after 
one week of culture and remained so for another week, with average TEER 
values of 860±160 Ω per cm2. Transcriptional analysis of cell lineage 
markers confirmed the presence of epithelial cells, stem cells, Paneth cells, 
proliferative cells, enteroendochrine cells, goblet cells and tuft cells in both 
enteriods and enteroid-derived 2D monolayers. However, the transfer from 
3D enteroids to 2D monolayers slightly modified the relative expression 
levels of these markers, possibly indicating a decrease of goblet- and paneth 
cells in the monolayers. Furthermore, both enteroids and monolayers 
expressed the genes encoding TLR2 and TLR5, but not TLR4.  
5.5 Cytokine responses to TLR-agonists in enteroid-
derived 2D monolayers 
To assess the responsiveness of the enteroid-derived 2D monolayers to 
microbial stimuli, monolayers were exposed to the TLR agonists Pam3CSK4 
(TLR2/1), Poly I:C (TLR3), LPS (TLR4) or FliC (TLR5) for 20 h followed 
by transcriptional analysis of cytokine genes (Paper III). No morphological 
changes were observed after exposure to Pam3CSK4, LPS or FliC. However, 
exposure to the TLR3 agonist poly I:C resulted in disruption of the 
monolayer with a high number of floating cells in the culture medium. In 
accordance, poly I:C was the only TLR agonist that induced gene expression 
of the alarmins TGF-β and IL-33. In addition, poly I:C induced high levels 
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of IFN-β mRNA as well as the pro-inflammatory cytokines TNF-α and IL-
8. Induction of TNF-α and IL-8 was also recorded in the monolayers exposed 
to Pam3CSK4 and LPS whereas monolayers exposed to FliC only up-





















Figure 10. Cytokine responses to TLR-agonists in equine enteroid-derived monolayers. 
Both Pam3CSK4 (TLR2/1) and LPS (TLR4) induced gene expression of IL-8 and 
TNF-α, while FliC (TLR5) only induced TNF-α. Exposure to poly I:C resulted in up-












5.6 Exposure of enteroid monolayers to S. vulgaris in the 
presence of Th polarizing cytokines (Addendum) 
To study interactions of S. vulgaris larvae with the intestinal epithelium, 
exsheated S. vulgaris L3s were added to the apical surface of enteroid 
monolayers cultured on transwell membranes in plain growth medium or 
pre-exposed to the Th1 polarizing cytokine IFN-γ or the Th2 polarizing 
cytokines IL-4 and IL-13 on the basolateral surface. After 20 h exposure to 
S. vulgaris exL3s, the enteroid monolayers were analyzed for their 
expression of cell lineage markers. The enteroid monolayers cultured in the 
presence of IL-4 and IL-13 slightly up-regulated the goblet- and tuft cell 
markers MUC2 and DCLK1, respectively. Apical exposure to S. vulgaris 
exL3s further up-regulated MUC2 and DCLK1 in IL-4 and IL-13 primed 
monolayers. In contrast, exposure to S. vulgaris exL3s on monolayers 
cultured in the absence of IL-4 and IL-13 did not seem to affect the 
expression of MUC2 or DCLK1. Furthermore, culture of monolayers in the 
presence of IFN-γ appeared to increase the expression of the Paneth cell 
marker LYZ (Figure 11). Thus, these preliminary data indicate that the 
equine enteroid-derived monolayers are responsive to the cytokine milieu 
created at the basolateral surface, affecting the cellular composition and the 
response to stimuli at the apical surface.   
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Figure 11. Relative gene 
expression of cell lineage 
markers for goblet cells 
(MUC2), tuft cells (DCLK1) 
and Paneth cells (LYZ) in 
transwell cultures of equine 
enteroid-derived 2D 
monolayers basolaterally 
primed with IFN-γ or IL-4 
and IL-13 after 20h apical 
exposure to S. vulgaris exL3s. 
The gene expression was 
normalized to the geometric 
mean for the reference genes 
(GAPDH, SDHA and HPRT) 































5.7 Exposure of enteroid monolayers to S. vulgaris at co-
culture with eqPBMC 
 To study interactions between the intestinal epithelium and immune cells at 
S. vulgaris infection, a co-culture model was developed from equine 
enteroid-derived 2D monolayers and eqPBMCs (Figure 5D). Enteroid 
monolayers were cultured on transwell membranes in connection with 
eqPBMCs cultured in the basolateral compartment and exposed to S. vulgaris 
exL3s on the apical surface of the monolayer. After 20 h S. vulgaris 
exposure, transcriptional analysis of cytokine genes was conducted in the 
enteroid monolayers and in the eqPBMCs. The preliminary results show that 
the only gene induced in the monolayers by S. vulgaris exposure was IL-8. 
The genes encoding IL-5, IL-33 and TGF-β were not differentially expressed 
while expression of IFN-γ, IL-4 and IL-13 were undetectable in the 
monolayers. In the eqPBMCs, an up-regulation of the gene encoding IL-5 
was recorded while the other cytokine genes tested (IFN-γ, IL-1β, IL-4, IL-
5, IL-8, IL-10, IL-13 IL-17A and TGF-β) were not differentially expressed 
(Figure 12). Furthermore, the genes encoding IL-9, TNF-α and TSLP were 
occasionally detected in both monolayer and eqPBMC cultures but with very 















Figure 12. Relative expression of cytokine genes in co-cultures of enteroid monolayers 
and eqPBMCs challenged with S. vulgaris exL3s. The gene expression was normalized 
to the geometric mean for the reference genes (GAPDH, SDHA and HPRT) and 




To test the effect of the G3 adjuvant or SvSXP protein in the co-culture 
system, eqPBMCs were primed with 5 μg/mL G3 or 2 μg/mL SvSXP for 18 
h prior to the co-culture experiment. In G3-primed eqPBMCs, the up-
regulation of IL-5 appeared to be higher compared to that in SvSXP-primed 
and non-primed eqPBMCs after apical exposure to S. vulgaris exL3s (Figure 
13a). In the enteroid monolayers in co-culture with G3-primed or non-primed 
eqPBMCs, a slight up-regulation of the gene encoding IL-8 was indicated 
after exposure to S. vulgaris exL3s (Figure 13b). Furthermore, TEER 
analysis indicate that neither the S. vulgaris exL3s nor the G3 adjuvant 
affected the monolayer integrity during this 20 h incubation (Figure 14). 






















Figure 13. The relative expression of IL-5 (A) and IL-8 (B) in co-cultures of enteroid 
monolayers and eqPBMC after apical exposure to S. vulgaris exL3s. Non-exposed 















Figure 14. Transepithelial electrical resistance (TEER) in equine enteroid-derived 
monolayers in co-culture with non-primed eqPBMCs or eqPBMCs primed with 5 μg/mL 
G3 or basolaterally exposed to 5μg G3/mL. The co-cultures were apically exposed S. 
vulgaris exL3s and TEER was measured after 20 h incubation. The results are given as 
mean values ± SD for three technical replicates.  
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Concerns about antimicrobial resistance combined with an increased 
prevalence of S. vulgaris reported in Sweden motivates development of new 
prophylactic tools to control this parasite. Initial immunization studies using 
orally administrated irradiated S. vulgaris L3 demonstrated that a protective 
immunity against S. vulgaris can be achieved by vaccination (Klei, 2000). 
Acquiring large amounts of live helminths is however impractical and 
ethically problematic as it would require the maintenance of experimentally 
infected “donor” horses. A more feasible option would therefore be a subunit 
vaccine based on recombinant S. vulgaris proteins. Such a vaccine requires 
identification of relevant vaccine antigens as well as an appropriate adjuvant 
that can increase and prolong the immunogenicity of the vaccine. To do this, 
we need a better understanding of the protective mechanisms against S. 
vulgaris. The initial studies on S. vulgaris performed in Kentucky indicate 
that immune protection is correlated with Th2 cytokines such as IL-5 and 
production of antibodies, predominantly IgG(T), that are recognizing the 
early larval stages of S. vulgaris. It is widely acknowledged that Th2 
responses are necessary for immune protection against most helminth 
species, although this dogma was recently challenged by Perera & Ndao 
(2021). Assembled data in this review suggest that for some helminth species 
Th1-driven mechanisms may be important to combat juvenile larvae at initial 
infection while Th2-driven mechanisms are necessary for expulsion of adult 
worms. Regardless, the intrinsic ability of helminths to manipulate the host’s 
immune response needs to be defined and potentially counteracted to achieve 
immune protection. It is therefore essential to understand the biology of the 




Research into helminths and immunology has traditionally relied on the 
use of animals. While studies in large animals is expensive and demand 
plenty of resources, murine models are cheaper and easier to manage. 
However, the murine models cannot always fully recapitulate immune 
responses in out-bred large animal species (Guzman & Montoya, 2018; Bush 
et al, 2020). Adding the fact that most helminths are host-specific motivates 
development of ex vivo systems based on cells or tissues isolated from the 
target species. Naturally, ex vivo models cannot replace the complexity of a 
living organism but they can be useful as an initial screening tool to build 
theories that later can be tested and confirmed in the living animal. In this 
thesis, I have used cultures of eqPBMC and equine enteroids to model both 
systemic and local reactions to infective stage S. vulgaris larvae. In addition, 
the immunomodulatory capacity of the novel adjuvant G3 together with S. 
vulgaris preparations was evaluated.   
 
There is currently an incomplete knowledge of the host-parasite 
interactions and immune mechanisms conferring protection to S. vulgaris. 
Considering its complex life cycle comprising several larval molts, S. 
vulgaris likely express a plethora of antigenic components at each larval 
stage. To study how different larval stages of S. vulgaris influence the 
immune response, eqPBMC were cultured in the presence of UV-attenuated 
L3s, exsheated L3s (exL3s) or L4s. Transcriptional analysis of cytokine 
genes indicate that the L3 and exL3 stage induce a typical helminth 
associated Th2 response characterized by up-regulation of IL-4, IL-5, IL-9, 
IL-13 and TSLP. Although the L4s also induced these cytokines, this stage 
appear to skew the Th2 profile by inducing the Th1 polarizing cytokine IFN-
γ. As the L4 is the life cycle stage when S. vulgaris first encounter peripheral 
blood, this observation may be important to understand the initial response 
to this parasite. While development of Th2 responses is considered essential 
for immune protection against helminths, Th1 responses have been 
associated with establishment of chronic infections. Studies in mice 
demonstrate that primary infection with T. muris induce a pro-inflammatory 
response with production of Th1 cytokines, such as IL-12 and IFN-γ, 
inhibiting activation of protective Th2 responses (e.g. Else et al, 1992; 
Bancroft et al, 1994; Humphreys et al, 2004). In addition, the murine GI 
nematode H. polygyrus was shown to induce IL-1β early during infection 
inhibiting expression of IL-25 and IL-33 allowing establishment of chronic 
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infection (Zaiss et al, 2013). Thus, these murine studies indicate that 
helminth antigens can alter polarization of the Th profile by induction of pro-
inflammatory and Th1 polarizing cytokines to promote establishment in the 
host. It is therefore tempting to speculate that the IFN-γ induction by S. 
vulgaris L4, observed in the present study, contributes to S. vulgaris 
establishment in the equine host. Reports from other helminth species that 
also spend parts of their life cycle in peripheral blood, such as Fasciola 
hepatica, Schistosoma mansoni, Brugia malayi and Trichinella spiralis, 
indicate that a mixed Th1/Th2 response is necessary for immune protection 
(reviewed by Perera & Ndao, 2021). Indisputable, further studies are 
necessary to scrutinize the role of IFN-γ during the initial response to S. 
vulgaris.  
 
Interestingly, the preliminary results indicate that the recombinant S. 
vulgaris SXP protein (SvSXP) protein also induce gene expression of IFN-γ 
as well as IL-17A and IL-2 in eqPBMC. The SvSXP protein was identified 
using migratory larvae at the L5 stage (Andersen et al, 2013b) and its 
expression by earlier stages remains to be confirmed. However, other 
SXP/RAL-2 proteins homologous to SvSXP have been localized to the worm 
intestine, hypodermis, cuticle and excretory glands as well as found among 
ES-products (Tsuji et al, 2001; Caballero et al, 2008), suggesting that SvSXP 
may be an excretory protein. Several proteins from the SXP/RAL-2 family 
have besides being studied as vaccine antigens or diagnostic markers also 
been identified as allergens in humans (García-Mayoral et al, 2014; 
Ahumada et al, 2020). A potential allergenic activity of some SXP/RAL-2 
proteins might complicate their use as vaccine antigens and further stress the 
importance of inducing a balanced Th1/Th2 response to the antigen.  
 
Many of the keys to designing an effective vaccine against S. vulgaris are 
likely to be found by studying its life cycle. During the early phase of 
infection, the S. vulgaris L3s and early L4s reside in the intestinal mucosa 
before beginning the migratory route through the mesenteric arterial system. 
A vaccine against S. vulgaris should optimally target these early larval stages 
to stop migration into the small blood vessels of the intestinal mucosa. To 
get a better understanding how S. vulgaris interacts with its equine host, it is 
therefore essential to study reactions to S. vulgaris also at the site of entry. 
For that purpose, equine enteroid cultures were generated from adult stem 
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cells isolated from equine jejunum. To allow S. vulgaris interaction studies 
with enteroid cells, 2D monolayer cultures were established from the equine 
enteroids. Both the enteroids and the enteroid-derived 2D monolayers 
contained cell lineages normally found in the equine small intestine 
(Gonzalez et al, 2015), such as intestinal stem cells, progenitor cells, Paneth 
cells, enteroendocrine cells and goblet cells. In addition, tuft cells were 
detected using doublecortin-like kinase 1 (DCLK1) which is a commonly 
used marker to identify tuft cells. In the healthy intestine, DCLK1 is uniquely 
expressed by a majority of tuft cells (Gerbe et al, 2009; Middelhoff et al, 
2017) but can also be selectively expressed by several kinds of cancer stem 
cells (Cao et al, 2020). Although, the role of tuft cells in the equine intestine 
remains to be elucidated, expression of DCKL1 was recently confirmed in 
different sections of the equine intestine by transcriptome analysis (Coleman 
et al, 2020). Recent studies in mice demonstrate that intestinal tuft cells play 
an important role in the defense against helminths. Tuft cells are an important 
source of IL-25 that drives the tuft-ILC2s signaling feedback loop in which 
ILC2s are activated to produce Th2 cytokines, such as IL-5, IL-9 and IL-13. 
The presence of IL-13 skews the differentiation pattern of the epithelium 
towards goblet- and tuft cells resulting in a rapid increase of these cell types 
during helminth infection (Schneider et al, 2019). In the horse, goblet cell 
hyperplasia has been described in horses with cyathostomin infection 
showing that expression of MUC2 and IL-13 in the large intestine and 
peripheral blood, respectively, can be correlated to worm burdens (Steuer et 
al, 2020). In the present thesis, increased expression of MUC2 and DCLK1 
was indicated in enteroid-derived 2D monolayers after basolateral exposure 
to IL-4 and IL-13. Apical challenge with S. vulgaris exL3 on monolayers 
primed with IL-4/IL-13 further increased the expression of these cell lineage 
markers indicating that helminth-induced goblet- and tuft cell hyperplasia 
can be replicated in the present ex vivo model.  
 
It is well established that the interplay between the intestinal epithelium 
and resident immune cells are important for initiating immune responses 
against helminth infections (Inclan-Rico & Siracusa, 2018). The intestinal 
epithelium can respond to helminth PAMPs by cytokine and/or chemokine 
production or respond to tissue damage caused by helminth invasion by 
production of alarmins. The function of the enteroid monolayers was 
therefore further assessed by analyzing their expression of cytokine genes at 
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exposure to defined TLR agonists mimicking bacterial and viral PAMPs. 
Apical exposure to TLR2/1, 3, 4 and 5 agonists triggered gene expression of 
pro-inflammatory cytokines and the viral mimic poly I:C (TLR3) was the 
only one to induce IFN-β indicating that the equine enteroid monolayers can 
respond to microbial structures in a similar fashion as expected in vivo 
(Andrews et al, 2018). When challenged with S. vulgaris exL3s, no 
differential cytokine expression was recorded in the enteroid monolayers. 
However, S. vulgaris challenge on enteroid monolayers in co-culture with 
eqPBMC induced a slight up-regulation of IL-8 in the enteroid cells, but not 
in the eqPBMC.  On the contrary, up-regulation of IL-5 was recorded in the 
eqPBMCs, but not in enteroid cells, suggesting a cross-communication 
between the enteroid monolayer and eqPBMCs at S. vulgaris challenge. 
Although methods to co-culture enteroid cells with immune cells are 
emerging (e.g. Staab et al, 2020; Schreurs et al, 2021), the use of such co-
cultures in studies of host-microbe interactions are hitherto few and have 
mainly been focused on bacterial infections in humans and mice (e.g. Noel 
et al, 2017; Schulte et al, 2020). However, the transwell co-culture system 
established in the present thesis using eqPBMCs and equine enteroid 
monolayers could be a valuable tool in future studies of host-GI parasite 
interaction in the horse.  
 
 Except for immunological studies, transwell systems have been widely 
used to study changes of epithelial barrier integrity at exposure to external 
factors, such as microorganisms, feed components or medical compounds 
(Srinivasan et al, 2015). Such a culture system was for example demonstrated 
by Noel et al (2017) that evaluated barrier integrity and cytokine production 
to different E. coli strains in human enteroid-macrophage co-cultures. Given 
the invasive nature of most helminth species, transwell culture of enteroid 
monolayers are not only interesting in terms of co-culture with immune cells 
but may also be used to elucidate the mechanisms involved in tissue invasion. 
In the present thesis, the epithelial barrier integrity, estimated by TEER, 
remained unchanged after 20 h exposure to living S. vulgaris exL3s 
indicating no disruption of the monolayer during this short incubation time. 
Since the mechanism(s) of larval penetration through the intestinal mucosa 
by S. vulgaris is unknown, appropriate culture conditions for triggering 
larval invasion is yet to be defined.  
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Early vaccination trials using attenuated S. vulgaris L3 or soluble somatic 
extracts indicate that the antigen should preferentially be administrated via 
the oral route (Monahan et al, 1994; Edmonds, 2001). A major challenge 
with orally administered vaccines is to compose an immunogenic 
formulation, especially when it comes to non-living or subunit antigens. The 
default mode in the intestine to these types of antigens is tolerance or 
ignorance. To break the tolerogenic milieu, an adjuvant suitable for 
administration at mucosal surfaces needs to be included in the vaccine 
formula. While adjuvants based on toxins from Cholerae and E. coli are most 
commonly used in mucosal vaccines for humans (Lavelle & Ward, 2021), 
ISCOMs have been successfully included in a number of experimental 
mucosal vaccines, either standalone (e.g. Kazanji et al, 1994; Coulter et al, 
2003; Crouch et al, 2005; Zhang et al, 2014) or formulated with toxoid 
compounds (Lycke, 2004). In the horse, a “systemic prime/mucosal boost 
strategy” using an ISCOM-based intranasal booster generated protection 
against equine influenza (Crouch et al, 2005). Furthermore, ISCOMs have 
successfully been included in oral experimental vaccines against protozoan 
parasites (Kazanji et al, 1994; Zhang et al, 2014). The efficacy of ISCOMs 
at mucosal surfaces is considered to rely on its ability to carry and deliver 
protein antigens to APCs (Mowat et al, 1999). A similar mode of action is 
plausible for the G3 adjuvant that can be formulated to incorporate additional 
molecules. Preliminary results from phenotyping eqPBMCs stimulated with 
the G3 adjuvant and the TLR2/1 agonist Pam3CSK4 suggests that the G3 
adjuvant, similar to ISCOMs, may target APCs. Furthermore, the evaluation 
of cytokine responses to the G3 adjuvant in cultures of eqPBMC indicates 
that G3 pre-dominantly induces a Th1 polarizing profile characterized by 
induction of IL-12p40 and IFN-γ. A Th1 skewed cytokine profile was also 
observed in porcine PBMCs after in vitro exposure to the G3 adjuvant 
(Hjertner et al, 2018b), and inclusion of the G3 adjuvant in an experimental 
influenza vaccine generated a mixed Th1/Th2 response in mice (Hjertner et 
al, 2018a).  
 
How an adjuvant should be formulated to optimally induce immune 
protection against helminth antigens in the mucosa is not entirely clear. 
Suggestively, a mucosal adjuvant should include components that enable 
uptake across the mucosal barrier, e.g. by targeting M-cells. This will 
facilitate antigen presentation by mucosal DCs that can in turn enhance T 
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cell priming and development of long-lasting plasma cells and memory B 
cells (Gerdts et al, 2005; Lycke, 2012). Indeed, methods to differentiate M 
cells in enteroid cultures are emerging (Kanaya et al, 2018), possibly 
enabling ex vivo screenings of adjuvant compounds aimed to target M cells 
in the future. Moreover, as mucosal DCs play a central role in priming 
immune responses, targeting specific mucosal DC subsets, such as CD103+ 
DCs, could direct systemic responses towards mucosal sites (Ruane & 
Lavelle, 2011; Lycke, 2012). In this context, bacterial flagellin has gained 
attention for its ability to target immune cells of the intestinal mucosa 
(reviewed by Cui et al, 2018). Systemic immunization with FliC, isolated 
from Salmonella enterica serovar Typhimurium, were shown to drive TLR5-
dependent recruitment of CD103+ DCs in the mesenteric lymph nodes 
resulting in an increased local differentiation of Treg cells and class 
switching to IgA (Flores-Langarica et al, 2012). In the present thesis, the 
immunomodulatory effect of the G3 adjuvant in combination with FliC was 
studied in cultures of eqPBMC. The results indicate that the G3 adjuvant can 
enhance the FliC-induced gene expression of IL-8 while simultaneously 
reduce the gene expression of IL-10. A similar effect on the IL-10 gene 
expression was recorded in eqPBMC after combining G3 with Pam3CSK4. 
As many helminths are known to manipulate the host’s immune response to 
produce IL-10, this feature makes the G3 adjuvant an interesting candidate 
adjuvant for use in equine vaccines with prospects of evading antigenic 
undesired immune reactions. The inactivated larval preparations of S. 
vulgaris generated in the present thesis did not induce gene expression of IL-
10 in eqPBMCs. However, as most immunomodulatory actions by helminths 
are mediated through ES-products (Maizels et al, 2018), an induction of IL-
10 at S. vulgaris infection should not be ruled out. The Th1 polarizing 
capacity of the G3 adjuvant also occurred in the presence of S. vulgaris L3s, 
as shown by up-regulation of IFN-γ and down-regulation of IL-4 and IL-5. 
Together, these in vitro data suggest that the G3 adjuvant can balance Th2 
polarizing immune responses towards a mixed Th1/Th2 profile in the horse.  
 
Taken together, work within this thesis has extended previous knowledge 
on the biology of S. vulgaris infection and advanced the ex vivo tools for 
further studies on GI pathogens in the horse and/or initial screening of 








 As S. vulgaris also invades the submucosa of the large intestine, future 
studies should focus on generation of equine colonoids.   
 
 Since the mechanism(s) of larval penetration through the intestinal 
mucosa is unknown, future studies should elucidate these mechanisms.  
 
 To aid targeting the intestinal mucosa, targeting molecules such as FliC 
will be considered in future vaccine designs against S. vulgaris. 
 
 The candidate vaccine components identified in this thesis should be 
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The equine large strongyle (Strongylus vulgaris) is considered to be the most 
dangerous parasite of horses. Recent reports of an increased prevalence of S. 
vulgaris in Sweden along with concerns about drug resistance motivates 
development of a vaccine to control this parasite.  
 
Formulation of vaccines against intestinal worms have always been a 
challenge. Gastro-intestinal (GI) worms commonly progress from eggs 
through multiple developmental stages, referred to as “larval (L) stages” until 
becoming adult worms. The various developmental stages are separated by 
molting events when the cuticle surrounding the larval body is released. 
These shifts between larval stages are typically fast and accompanied by 
migrations through different organs and tissues. In addition, molecules 
produced and released by helminths referred to as excretory-secretory (ES) 
products are immunomodulatory, meaning that they can interfere with the 
host’s immune response. Rapid shifts between larval stages along with the 
parasite’s inbuilt capacity to manipulate immune responses makes it difficult 
for the immune system to mount a response needed to develop 
immunological memory. To guide the immune response on the right path, 
immune stimulatory substances, called adjuvants, can be included in the 
vaccine formula to increase vaccine efficiency. 
 
A better understanding how GI worms interact with the host’s immune 
system and how unwanted immunological reactions can be balanced are 
critical to develop effective vaccines against GI worms. To address these 
issues, immune reactions to S. vulgaris larvae and a novel adjuvant called 
“G3” were studied in laboratory cell culture models built up by immune cells 
isolated from equine blood (PBMC) and stem cells isolated from the intestine 
(enteroids).  
Popular science summary 
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Immune reactions to S. vulgaris larvae and/or the G3 adjuvant were 
mainly estimated by qPCR analysis of cytokine genes. Cytokines are small 
signaling proteins that play an essential role in initiation of immune 
responses. By measuring cytokine genes, we can in theory get a good idea 
how certain stimuli act on immune cells and what the ensuing immune 
response will be like. 
 
Enteroids are three-dimensional lab-grown “miniature intestines” 
resembling the composition and function of the real intestine. To enable 
studies of host-parasite interactions in the equine intestine, methods to 
culture enteroid cells on a two-dimensional plane, as a “monolayer”, were 
established. The equine enteroids and enteroid monolayers were evaluated 
with regards of their cell composition and responsiveness to bacterial or viral 
mimics. The equine enteroid monolayers displayed genetic and functional 
similarities with the equine intestine making it a suitable laboratory model 
for studies of host-GI parasite interactions in the horse.  
 
It is well established that the interplay between the cells of the intestinal 
barrier and underlying immune cells are important for initiating immune 
responses against worm infections. Therefore, the enteroid culture system 
was further expanded using enteroid monolayers co-cultured with equine 
PBMCs. A simulated infection with S. vulgaris exL3s indicate a cross-
communication between the enteroid monolayer cells and the equine 
PBMCs. Thus, this co-culture model can therefore be used to generate 
additional knowledge how immune cells reacts to intestinal parasites during 
the early phase of infection. 
 
Horses are infected by S. vulgaris by ingesting infective third stage larvae 
(L3) on pasture. During the first phase of infection, the larvae penetrate the 
intestinal wall and mature to the fourth larval stage (L4) before starting its 
migration through the blood vessels of the intestine. To study how these early 
life cycle changes influence the immune response, methods for culture of S. 
vulgaris from the third to the fourth stage were established, generating three 
S. vulgaris preparations defined as “L3”, “exsheated L3” (exL3) and “L4”. 
Cultures of equine PBMC were thereafter exposed to larvae weakened by 
UV-irradiation and analyzed for their expression of cytokine genes. The 
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results show that both S. vulgaris L3 and exL3 induced gene expression of 
cytokines that is typically associated with worm infection. The L4 stage, 
however, induced a skewed cytokine profile compared to the earlier stages 
indicating that the developmental stages in the life cycle of S. vulgaris may 
generate different immune responses. This diversity depending on the life 
cycle stage will likely have implications for the choice of components to 
include in a future vaccine. 
 
To increase vaccine efficiency, an adjuvant is commonly included in the 
vaccine formula. Our studies on the he G3 adjuvant show an up-regulation 
of cytokine genes not typically associated with a parasitic response. 
However, the G3 adjuvant were shown to balance the response by other 
immunostimulatory compounds and S. vulgaris L3s. This feature makes G3 
is an interesting candidate adjuvant for use in equine vaccines with prospects 
of balancing undesired immune responses.  
 
To sum up, this thesis adds on new knowledge about the diversity of the 
cytokine response to different larval stages of S. vulgaris, which is important 
to understand the initial response to this parasite. Establishment of equine 
enteroids and enteroid monolayers brings new possibilities to study 
interactions between S. vulgaris and the equine intestine and can in future 






Den stora blodmasken (Strongylus vulgaris) anses vara hästens farligaste 
parasit. Rapporter om en ökad förekomst av S. vulgaris i Sverige samt risken 
för resistensutveckling mot avmaskingsmedel motiverar utvecklingen av ett 
vaccin för att bekämpa denna parasit.  
 
Framställning av vacciner mot inälvsmaskar har alltid varit en utmaning. 
Inälvsmaskar utvecklas vanligtvis från ägg genom flera utvecklingsstadier, 
kallade ”larv (L) stadier” tills de blir vuxna maskar. Mellan de olika 
utvecklingsstadierna släpper larven sitt yttre hölje vilket ofta åtföljs av 
migrationer genom olika organ och vävnader. Dessutom kan larver utsöndra 
så kallade ”ES-produkter” som kan påverka värddjurets immunförsvar. 
Snabba skiften mellan olika larvstadier tillsammans med parasitens inbyggda 
förmåga att vilseleda värddjurets immunsvar gör det svårt formulera ett 
effektivt vaccin mot inälvsmaskar. För att leda immunförsvaret på rätt väg 
kan ett immunstimulerande ämne, ett så kallat adjuvans, tillsättas för att öka 
vaccineffekten.  
 
En bättre förståelse för hur inälvsmaskar interagerar med värddjurets 
immunförsvar och hur oönskade immunologiska reaktioner kan balanseras 
är avgörande för att utveckla effektiva vacciner mot inälvsmaskar. För att 
studera hur S. vulgaris interagerar med hästens immunförsvar, användes 
cellodlingsmodeller uppbyggda av immunceller från hästens blod 
(mononukleära blodceller) och stamceller isolerade från hästens tarm 
(enteroider) för att studera immunreaktioner mot S. vulgaris larver och ett 




Immunreaktioner mättes framförallt genom qPCR-analys av cytokiner. 
Cytokiner är små signalproteiner som spelar en viktig roll vid initiering av 
ett immunsvar. Genom att mäta uttryck av gener som kodar för cytokiner kan 
vi i teorin få en uppfattning om hur vissa stimuli verkar på immunceller och 
hur det efterföljande immunsvaret kan komma att se ut.  
 
Enteroider är tredimensionella labb-odlade ”miniatyrtarmar” som liknar 
den verkliga tarmens sammansättning och funktion. För att kunna studera 
interaktioner mellan S. vulgaris och hästens tarm etablerades metoder för att 
odla enteroida celler som ett s.k. monolayer, d.v.s. ett enskiktat lager av 
celler. Enteroiderna och enteroida monolayers utvärderades med avseende 
på deras uppsättning av celltyper och förmåga att inducera cytokiner vid 
stimulering med strukturer typiska för bakterier och virus. De enteroida 
monolayerna visade både genetiska och funktionella likheter med hästens 
tarm vilket gör dem till en lämplig laboratoriemodell för att studera 
inälvsparasiter i häst.  
 
Det är välkänt att samspelet mellan tarmcellerna och underliggande 
immunceller är viktigt för att initiera ett immunsvar mot inälvsmaskar. 
Därför utvecklades det enteroida odlingssystemet ytterligare genom att 
samodla enteroida monolayer med ekvina immunceller. En simulerad 
infektion med infektiösa S. vulgaris larver indikerade att tarmcellerna 
kommunicerar med immuncellerna genom produktion av cytokiner. Denna  
samodlingsmodell skulle därför kunna användas för att generera ytterligare 
kunskap om hur immunförsvaret reagerar mot inälvsparasiter under det 
tidiga infektionsskedet.   
 
Hästar infekteras av S. vulgaris när de får i sig infektiösa tredje stadiets 
larver (L3) på ett smittat bete. Under den första infektionsfasen penetrerar 
larverna tarmväggen och mognar till det fjärdelarvstadiet (L4) innan de 
börjar migrera genom tarmens blodkärl. För att studera hur dessa tidiga 
livscykelförändringar påverkar immunsvaret, etablerades metoder för odling 
av S. vulgaris larver från det tredje till fjärde larvstadiet. Detta genererade 
tre S. vulgaris preparat definerade dom ”L3”, ”exL3” och ”L4”. Ekvina 
immunceller exponerades därefter för dessa larvpreparationer försvagade 
genom UV-bestrålning. Resultaten visar L3 och exL3 stadierna av S. 
vulgaris inducerar cytokiner som är typiskt associerade med maskinfektion. 
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Till skillnad från de tidigare stadierna, inducerade L4 stadiet en avvikande 
cytokinprofil vilket antyder att olika utvecklingsstadier av S. vulgaris kan ge 
upphov till olika immunsvar. Dessa olikheter i immunsvar beroende på 
livscykelstadie kommer sannolikt att påverka valet av komponenter som bör 
inkluderas i ett framtida vaccin mot S. vulgaris.    
 
För att öka vaccineffektiviteten brukar vanligtvis ett adjuvans tillsättas. 
Våra studier på G3 adjuvanset visar på en uppreglering av cytokiner som 
vanligtvis inte brukar associeras med tarmparasiter. Dock kunde G3 
adjuvanset balansera cytokinsvaret mot andra immunstimulerande ämnen 
och S. vulgaris larver. Denna egenskap gör G3 adjuvanset intressant att 
fortsätta utvärdera för användning i hästvacciner där ett oönskat immunsvar 
behöver balanseras. 
 
Sammanfattningsvis bidrar arbetet inom denna avhandling till ny kunskap 
om cytokinsvaret mot olika larvstadier av S. vulgaris, vilket är viktigt för att 
förstå hur immunförsvaret reagerar vid ett tidigt infektionsskede. Etablering 
av nya cellodlingssystem baserat på hästens tarmceller ger nya möjligheter 
att studera interaktioner mellan S. vulgaris och hästens immunförsvar i 
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